Prevalence of traditional Chinese medicine and other complementary and alternative medicine use among Chinese cancer patients in British Columbia, Canada by Ferro, Mark Anthony
  
PREVALENCE OF TRADITIONAL CHINESE MEDICINE AND OTHER 
COMPLEMENTARY AND ALTERNATIVE MEDICINE 
USE AMONG CHINESE CANCER PATIENTS IN 
BRITISH COLUMBIA, CANADA 
 
 
 
 
 
A Thesis Submitted to the College of 
Graduate Studies and Research 
In Partial Fulfillment of the Requirements 
For the Degree of Master’s of Science 
In the Department of Community Health and Epidemiology 
University of Saskatchewan 
Saskatoon 
 
By 
 
MARK ANTHONY FERRO 
 
 
 
 
 
Keywords: Acculturation, Asian Continental Ancestry Group, 
Complementary Therapies, Neoplasms, Prevalence 
 
 
© Copyright Mark Anthony Ferro, August, 2006. All rights reserved. 
i 
PERMISSION TO USE 
In presenting this thesis in partial fulfilment of the requirements for a Post-graduate degree from the 
University of Saskatchewan, I agree that the Libraries of this University may make it freely available for 
inspection. I further agree that permission for copying of this thesis in any manner, in whole or in part, 
for scholarly purposes may be granted by the professor or professors who supervised this thesis work or, 
in their absence, by the Head of the Department or the Dean of the College in which this thesis work was 
done. It is understood that any copying or publication or use of this thesis or parts thereof for financial 
gain shall not be allowed without written permission from the author. It is also understood that due 
recognition shall be given to the author and to the University of Saskatchewan in any scholarly use which 
may be made of any material in this thesis. 
 
Requests for permission to copy or to make other use of material in this thesis in whole or part should be 
addressed to: 
 
 Head of the Department of Community Health and Epidemiology 
 University of Saskatchewan 
 Saskatoon, Saskatchewan  S7N 5E5 
ii 
ABSTRACT 
Purpose: Little is known about the use of complementary and alternative medicine (CAM), including 
traditional Chinese medicine (TCM) in ethnic populations with cancer living in Canada. The purpose of 
this study was to assess the prevalence and predictors of TCM/CAM use in newly diagnosed Chinese 
cancer patients who were starting cancer treatments. 
 
Patients and Methods: A consecutive sample of newly diagnosed Chinese cancer patients treated at the 
British Columbia Cancer Agency over a four month period was surveyed. During admission, the study 
questionnaire was distributed along with other registration forms and anonymously returned in well-
labeled boxes. A bilingual Chinese interpreter was available to answer any questions potential 
participants might have had. The 15-item questionnaire focused on TCM/CAM use, socio-demographics, 
and medical and cultural factors.  
 
Results: Ninety-one patients completed the questionnaire. The majority of respondents (90%) were born 
outside of Canada and 64% completed the questionnaire in Chinese. TCM/CAM was used by 44% of 
respondents. Herbal remedies, vitamins/minerals, and prayer were the most commonly used therapies. In 
the bivariate analysis, factors predicting TCM/CAM use were prior TCM/CAM use (p < 0.001), having 
received chemo/radiotherapy (p = 0.021), female sex (p = 0.015), immigrant status (p = 0.040), and 
reporting a non-official language most frequently used at home (p = 0.018).  Following multivariate 
analysis, it was found that prior CAM use (p < 0.001), lower income (p = 0.043), and immigrant status (p 
= 0.030) were associated with TCM/CAM use.  
 
Conclusion: TCM/CAM use in newly diagnosed Chinese cancer patients is very common and results are 
comparable to previous studies in other populations. Healthcare practitioners must become aware of the 
widespread use of CAM and engage discussions about CAM use with their patients, especially those of a 
specific ethno-cultural group who may be less acculturated to Western society.  
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1. INTRODUCTION 
Over the past decade, the worldwide use of complementary and alternative medicine (CAM), including 
various traditional Chinese medicine (TCM) modalities has been increasingly documented within the 
general adult population,1-4 and its popularity continues to grow in Canada.5-8 Research also suggests that 
an increasing number of cancer patients are using CAM primarily as adjunct to conventional cancer 
treatments.9-12 
 
1.1 Background 
As defined by the National Center for Complementary and Alternative Medicine (NCCAM), CAM 
encompasses “a group of diverse medical and healthcare systems, practices, and products that are not 
presently considered to be part of conventional medicine.”13 Within the realm of CAM, TCM is classified 
as a complete healthcare system with its own unique practices dating back to ancient China.14 Table 1.1 
lists the NCCAM’s system of classifying CAM modalities and therapies. When deconstructing the 
meaning of CAM, it is important to note that the term “alternative” is used for therapies that are 
substituted for mainstream conventional medicine, whereas “complementary” is the term used for 
therapies used in conjunction with, not as a replacement for conventional medicine. Several explanations 
proposed for the surge in popularity of CAM include, dissatisfaction with conventional treatment and/or 
the medical encounter15, 16 and the emergence of the postmodern philosophy.17 
 
Social changes, including globalization, which have given birth to postmodernism, include beliefs that 
science and technology will not create the utopian society promised in the middle of the last century and 
“green” movements with emphasis on natural and holistic solutions to problems have arisen.17 Such 
philosophies are congruent with those therapies practiced by CAM practitioners which help to explain 
that CAM users are not so much “pushed away” from conventional medicine as they are “pulled 
towards” CAM.18 Also, individualism and consumerism have infiltrated all aspects of society, including 
healthcare. Individuals are now less accepting of authority and seek greater control and empowerment 
over their lives.19 With the advent of the Internet and increased access to volumes of information,20 
patients have become more active in the physician-patient relationship; challenging practitioners’ 
regimens, exercising more power in the medical decision-making process, and as Eastwood comments, 
have caused “a diminution of biomedical prestige and authority.”21 
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Another reason for the growth of CAM in recent decades is Western society’s acceptance of other 
cultural views on health and illness due to the increase in human migration and exchange of medical 
knowledge from other healthcare systems (e.g., Ayurveda from India, TCM from China). CAM therapies 
as they are known today have existed for centuries as traditional medicine throughout the world. In fact, 
the majority of the world’s population uses traditional medicine as the major healthcare system and this 
trend is beginning to emerge in Western nations as well.22 
 
Table 1.1 – NCCAM classification of CAM therapies.13 
Domain Description Examples 
Alternative healthcare 
systems 
Alternative healthcare systems are built 
upon complete systems of theory and 
practice. Often, these systems have evolved 
apart from and earlier than the conventional 
medical approach used in most Western 
cultures. 
 
Ayurveda; Homeopathy; 
Naturopathy; TCM 
Mind-body interventions Mind-body medicine uses a variety of 
techniques designed to enhance the mind’s 
capacity to affect bodily function and 
symptoms. 
 
Meditation; Music therapy; 
Prayer; Support groups 
Biologically-based 
therapies 
Biologically based therapies in CAM use 
substances found in nature, such as herbs, 
foods, and vitamins. 
Ginseng; Green tea; Mega-
dose vitamins/minerals; 
Shark cartilage 
 
Manipulative and body-
based methods 
Manipulative and body-based methods in 
CAM are based on manipulation and/or 
movement of one or more parts of the body. 
 
Chiropractic; Massage 
Energy therapies Energy therapies involve the use of energy 
fields. 
Magnetism; Qi-gong; 
Reiki; Therapeutic touch 
 
As described in Chapter 2, a plethora of epidemiological studies reporting the prevalence of CAM use in 
various cancer populations have been published in the past ten years. A systematic review on CAM use 
reported an average prevalence of 31% (7 – 64%) across 26 studies in adult cancer patients in 13 
countries.23 Such huge variations are the result of several factors including the type and severity of the 
cancer, national characteristics, study methodology, and most critically, how CAM is defined by both 
researchers and patients. 
 
Canada has become increasingly multi-cultural and consequently the risk of cross-cultural 
misunderstanding during patient/family and healthcare practitioner encounters is steadily increasing. As a 
result, an understanding of the concept of culture is of utmost importance when studying a specific ethno-
cultural group. Due to intensely debated discussions among anthropologists surrounding its definition, 
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the term, “culture” is believed to be one of the most complex words in the English language and is 
defined differently by nearly every scholar who writes about the topic.  
  
As with most active research endeavors, the definition of culture has evolved during recent centuries. In a 
classic definition by Taylor in 1871, “Culture… taken in its wide ethnographic sense is that complex 
whole which includes knowledge, belief, art, morals, laws, custom, and any other capabilities and habits 
acquired by man as a member of society.”24 In 1952, Kroeber and Kluckhohn unified various definitions 
of culture into a single formulation when they wrote, 
 
Culture consists of patterns, explicit and implicit, of and for behavior acquired and 
transmitted by symbols, constituting the distinctive achievement of human groups, 
including their embodiments in artifacts; the essential core of culture consists of 
traditional (i.e., historically derived and selected) ideas and especially their attached 
values; culture systems may, on the one hand, be considered as products of action, on 
the other hand, as conditioning elements of further action.25 
 
Twenty years later, Geertz expressed culture as “webs of meaning through which particular humans in 
specific social settings interpret their existence.”24 Other recent attempts at defining culture appear to 
revolve around common themes of shared tradition, norms, and symbols. Mendyka and Bloom define 
culture as the framework by which experience, perception, and world view are patterned and given 
meaning.26 Leininger describes culture as the learned, shared, and transmitted values, beliefs, norms, and 
lifeways of a particular group that guide the group’s thinking, decisions, and actions in patterned ways.27 
Ting-Toomey states that culture is a complex frame of reference that consists of patterns, traditions, 
beliefs, values, norms, symbols, and meanings that are shared in varying degrees by interacting members 
of a community.28 It becomes obvious that culture, which we learn beginning in childhood, represents a 
way of perceiving, behaving, and evaluating the world. Ting-Toomey uses the iceberg model as an 
analogy of culture. As only a small fraction of an iceberg is visible above the water line, similarly, only 
the uppermost layers of an individual’s culture can be observed through verbal and non-verbal symbols. 
The deeper layers; traditions, beliefs, and values are hidden from view. It is these deeper layers that drive 
individuals’ thoughts, reactions, and behaviours. 
 
Furthermore, it is important to understand that the concept of culture is not static and is no longer simply 
used to explain the ways of life of societies, but refers to dominant values, symbols, social practices, and 
interpretive categories of a population.29, 30 The dynamic nature of culture was described in a recent 
article by Kleinman:31 
 
The term “culture” is often misused. In its early anthropologic usage, culture referred 
to the shared patterns of life that define social groups. This usage tended to portray 
cultures as bounded, fixed entities, neglecting crucial differences among and within 
groups, and it risked reducing culture to an autonomous variable among others. But 
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culture is not a thing; it is a process by which ordinary activities acquire emotional and 
moral meaning for participants. Cultural processes include the embodiment of meaning 
in habitus and physiological reactions, the understanding of what is at stake in 
particular situations, the development of interpersonal connections, religious practices, 
and the cultivation of collective and individual identity. Culture is inextricably caught 
up with economic, political, psychological, and biologic conditions. Treating culture as 
a fixed variable seriously impedes our ability to understand and respond to disease 
states. 
 
Not only is the fluidity of the “culture concept” highlighted, but culture’s affect on health and disease is 
brought to attention. The values, ideas, beliefs, and symbols of a specific culture directly influence the 
manner in which members experience, react to, and treat disease and bodily dysfunction, and what may 
be regarded as disease in one culture, may not be so regarded in another.32 Culture serves as the safety net 
in which individuals seek to satisfy their needs for identity, inclusion, and communication. Individuals of 
Chinese origin whose major philosophical and religious beliefs are rooted in Confucianism, Taoism, and 
Buddhism commonly refer to yin/yang, which has become the foundation of Chinese beliefs surrounding 
health, illness, and medical treatment within the doctrines of TCM.33 Although mainstream in its country 
of origin, TCM is considered an alternative healthcare system in the Western world. Within the Canadian 
cultural mosaic, it is imperative that the healthcare system have a clear understanding of the concept of 
culture in order to provide culturally appropriate, and culturally sensitive care to cancer patients of 
differing ethno-cultural origins. 
 
1.2 Problem Statement 
As discussed in Chapter 2, several recent studies document CAM use in Canada but none adequately 
focus on the cultural influences on CAM use in a specific ethno-cultural group. More specifically, very 
little is known about TCM and complementary and alternative health service utilization in the Chinese 
community whose members are diagnosed with cancer. Within British Columbia (BC), immigrants from 
China, Hong Kong, and Taiwan represent the largest ethno-cultural group. According to the 2001 
Canadian census, Chinese individuals represent the largest ethnic group in BC (9.4% of the provincial 
population) and within BC, the cities with the highest proportion of Chinese population are Richmond 
(39%), Vancouver (30%), and Burnaby (26%).34 Given the predominance of Chinese communities in BC, 
it is important that the health needs of this ethno-cultural group be addressed.  
 
1.3 Purpose 
The growing ethno-cultural diversity in Canada challenges oncology practitioners to develop culturally 
sensitive care strategies. Nevertheless, it is important to bear in mind the theoretical and practical 
difficulties of describing and understanding CAM utilization within the Canadian healthcare system from 
an ethno-cultural perspective. These difficulties may be attributed to the diversity in beliefs and customs, 
immigration history, degree of acculturation, place of origin, and religious background in these ethno-
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cultural populations. Within this context, the overall goal of the proposed research is to estimate the 
prevalence and identify the characteristics of TCM/CAM use among Chinese cancer patients in BC, and 
to briefly examine the influence of culture on TCM/CAM use within this population. Due to the paucity 
of research in this academic field, the following specific research objectives were addressed: 
 
1. To estimate the prevalence of TCM/CAM use among newly diagnosed Chinese cancer patients upon 
admission to the British Columbia Cancer Agency (BCCA).  
2. To identify socio-demographic, medical, and cultural characteristics predictive of TCM/CAM use 
among Chinese cancer patients according to Andersen and Newman’s model of health service 
utilization. 
3. To investigate differences in TCM/CAM and other characteristics between acculturated and less 
acculturated patients. 
4. To explore differences between male and female TCM/CAM users. 
 
1.4 Conceptual Framework 
This study was guided by Andersen and Newman’s model of health service utilization35 which is a 
widely recognized model that conceptualizes the diverse influences on health behaviour. According to 
this framework, factors that influence health service utilization (i.e., TCM/CAM use) can be classified 
into three broad categories: societal, healthcare system, and individual.36 Societal determinants are 
comprised mainly of technology (the principles and tools used to bring about change) and norms (ways 
or modes in which members of society comply). The healthcare system includes health-related services 
and goods such as, physician care, hospital care, and medications. Individual determinants, which have 
received the greatest research attention, are further categorized into predisposing, enabling, and illness 
level factors. A conceptual representation of the individual determinants of this model is illustrated in 
Figure 1.1.  
 
Predisposing factors are socio-demographic characteristics, social structures, and attitudes/beliefs 
surrounding health and disease which are thought to influence an individual’s propensity to use health 
services before the need for these services are present. Enabling factors are family- and community-level 
characteristics that facilitate or inhibit the ease in which heath services are obtained. Illness level factors 
including, perceived health status and established diagnoses are commonly viewed as the most important 
factors in determining whether an individual seeks out health services. This model served as the 
theoretical and conceptual framework for this study and guided development of the questionnaire and 
interpretation of results. 
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ENABLINGPREDISPOSING ILLNESS LEVEL HEALTH SERVICE UTILIZATION
DEMOGRAPHIC
Age
Sex
Marital Status
Past Illness
SOCIAL STRUCTURE
Education
Race
Occupation
Family Size
Ethnicity
Religion
Residential mobility
BELIEFS
Values concerning 
health & illness
Attitudes toward 
health services
Knowledge about 
disease
FAMILY
Income
Health Insurance
Type of regular source
Access to regular source
COMMUNITY
Ratios of HCP & 
facilities to population
Price of health services
Region of country
Urban-rural character
PERCEIVED
Disability
Symptoms
Diagnosis
General state
EVALUATED
Symptoms
Diagnoses
Figure 1.1 – Individual determinants of health services utilization.35 
HCP, healthcare practitioner. 
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2. LITERATURE REVIEW 
2.1 The Ethos of TCM 
Scholars attribute modern-day TCM as evolving from the folk medicine practiced during the Zhou 
dynasty (1027 – 221 B.C.) of ancient China, with the first classical book on TCM, “The Yellow 
Emperor’s Classic of Internal Medicine,” being written in the first century B.C., during the Han 
dynasty.37, 38 In addition to this sacred text, the major philosophical and religious beliefs from 
Confucianism, Taoism, and Buddhism have become the foundation of Chinese beliefs surrounding 
health, illness, and the theoretical basis of medical treatment within TCM.33 
 
Whereas Taoism is concerned mainly with how one lives in relation to one’s natural setting, 
Confucianism is concerned with how one lives in one’s social context.39 Specifically, Taoism emphasizes 
the importance of passive attitudes for physical and psychological harmony and well-being. According to 
Confucianism, good health is achieved through active social participation and that achieving individual 
health is secondary to maintaining social harmony and balance. Furthermore, in Buddhist doctrine, cause 
and effect are the principles that encourage people to do good and to receive good in return. Therefore, 
when people are morally good, they have inner peace, thus promoting their health and well-being.40 
However, even before the advent of Taoism, Confucianism, and Buddhism, theories of yin/yang and the 
five phases were devised in ancient China and resound still in modern times.  
 
As a symbolic representation of the universe, yin/yang, embodies the concept of change, relationships, 
patterns, and process at all levels of existence, whereby yin/yang mutually complement each other and 
are dependent on each for definition.37, 41 The qualities of yin/yang are polar opposites where yin has all 
the feminine attributes and is quiescent, yielding, static, contracting, cold, wet, and dark, while yang is 
masculine, dynamic, active, expansive, hot, dry, and light.42 As such, yin/yang represents all facets of 
Chinese philosophy and is fundamental concept in the natural sciences such as medicine, but also heavily 
influences social behaviours. The theory of the five phases states that all phenomena in the universe are 
shaped and affected by five entities; wood, fire, earth, metal, and water.41, 43 With respect to Chinese 
health beliefs, the five phases are the basis for the categorization of organs and the properties of 
medicinal drugs. 
 
Apart from the ideas of yin/yang and the five phases, there is no concept more crucial to TCM than qi – 
the idea that the body is pervaded by subtle material and mobile influences that cause most physiological
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functions and maintain the health and vitality of the individual.38, 41 Commonly, the term qi is translated 
to express the notion of energy; however, this translation is lacking. A recent review of TCM by Quah, 
refers to qi as “the basic substance from which the cosmos was made…very minute particles in 
continuous motion, the deep spring and the motive force in the transformation of things, and represents 
the link between the body and the universe.”42 Thus, it is reasonable to state that the ethos of TCM is 
based on the theories of yin/yang, the five phases, and the existence of qi. 
 
The concept of health within the realm of TCM is quite simple. Health is achieved through balance and 
harmony between the body and the universe, with respect to internal psychological functions as well as 
external social and ecological conditions, which cannot be quantified with conventional medical 
standards.39, 41, 44 Disease is a reflection of disharmony between the individual and the universe, or within 
the individual himself, and as such, disease is rarely localized, but generally affects the entire 
individual.45-47 In the case of cancer, as discussed by Beinfield and Korngold, the etiology of a malignant 
tumour is initiated by adverse pathogenic factors leading to the stagnation and depletion of qi, moisture, 
and blood, impairing the coordinated functioning of the organ system, thus leading to further weakness 
and obstruction of essence, the source of qi and blood.48 At some critical level of depleted qi, blood, and 
essence, yin/yang becomes separated, losing balance and harmony. Such disorganization leads to failure 
of the body to govern cellular differential and proliferation. Despite such a poetic ideology of health and 
disease, at the core of TCM doctrine, if a person is without symptoms, he is healthy.49 
 
Diagnosis of disease in TCM involves a highly comprehensive examination which gathers information 
that reflects the physiological status in order to determine the underlying cause of the disease.50 The 
process of assessment in TCM can be complex. Typically, four diagnostic methods are employed: 
inspection, auscultation/olfaction, inquiry, and palpation.50 Just as disease is a disruption of balance 
within an individual, treatment aims to restore balance and harmony utilizing the principle of yin/yang.43 
For example, a symptom complex whereby qi is deficient should be treated with a qi reinforcing method. 
Therapeutic methods employed by TCM practitioners include, acupuncture, moxibustion, cupping, 
Chinese massage, mind-body exercises, and Chinese herbal medicine. Although each can be used 
independently, TCM practitioners will generally use a combination of therapeutic methods to restore a 
harmonious equilibrium in patients. 
 
2.2 Pilot Study 
A pilot study among Chinese cancer patients was conducted by Chiu et al., in 2004.51 This qualitative 
study assessed the use of CAM among 14 Chinese cancer patients (six male, eight female) using an 
ethnographic interview methodology. In this study, Chinese was defined as individuals from China, Hong 
Kong, or Taiwan who were either first generation (i.e., immigrants) or second generation (i.e., child of 
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immigrants). Patients had a mean age of approximately 50 years and all but one patient were first 
generation Chinese. Thirteen patients reported Cantonese or Mandarin as their primary language and 
86% of patients had an education level of high school or above. All patients used at least one form of 
TCM. It was interesting to note that some patients did not relate TCM to CAM, as they perceived TCM 
to be part of their daily lives. The most common types of TCM modalities used were herbal medicine 
(79%), qi-gong (50%), food therapy (36%) and meditation (29%). 
 
Many of the reasons for using TCM were grounded in traditional Chinese beliefs about health and illness. 
Patients expressed the notion that TCM regulates and strengthens the body and cares for the mind and 
spirit. For example, TCM was used to replace qi after having surgery for their cancer. Other reasons for 
using TCM included the failure of conventional medicine, to cure cancer, having a previous positive 
experience with TCM, and by the encouragement of others within their social network. The decision to 
use TCM was seen as a four-phase process in which patients were involved in seeking information, 
examining the evidence, conducting an experiment, and then evaluating the outcomes. Influencing this 
process included factors such as Chinese cultural beliefs, social networks, and importantly, cost. As many 
of the patients were on fixed or no income, many scaled down their use of TCM or returned to their place 
of origin to receive treatment for their cancer. 
 
This pilot study provided the necessary groundwork for the present study. It exposed the wide use of 
TCM among Chinese-Canadians living with cancer, albeit in a small sample of patients. What was 
central to this study was the call for healthcare practitioners, especially those in the oncology setting to be 
mindful of cultural beliefs and practices of this specific ethno-cultural group. This study aims to build on 
this framework. 
 
2.3 CAM Use in Canadian Cancer Patients 
CAM use among the various cancer populations in Canada has been well documented. In a MEDLINE 
search from 1996 – 2005, a total of 13 publications were found investigating the prevalence of CAM use 
among cancer patients in Canada.52-64 The key data from these reports are summarized in Table 2.1. 
Increasing interest in CAM use among Canadian cancer patients is reflected in the steady growth in the 
numbers of publications on the subject, with five articles published in the latter part of the previous 
decade52-56 and eight publications thus far in the early part of this century.57-64 
 
Publications were based on research conducted across Canada, with the majority of studies coming from 
BC52, 60, 63 and Ontario55-57, 62 (three and four studies, respectively). Two studies were conducted in 
Alberta,53, 61 with Saskatchewan,59 Manitoba,54 Quebec,58 and Nova Scotia64 each having one study 
conducted in the respective province. The vast majority of these prevalence studies utilized a mail survey 
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in a cross-sectional study design,52, 57, 61-63 although two studies implemented in-person interviews with 
patients at cancer clinics,53, 56 and one study used a telephone interview for data collection.59 The 
measurement instruments, which consisted of a survey or questionnaire, were either structured or semi-
structured, and had been adapted from previous research and validated with the use of focus groups. Such 
methodologies were consistent with other research conducted elsewhere.65-73 
 
Table 2.1 – Studies investigating CAM use in Canadian cancer patients. 
Author, Year, & Site Study Sample Method CAM Therapies Prevalence 
Fernandez et al., 1998 
British Columbia 
Parents with a child 
with cancer (N=366) 
Self-administered 
questionnaire 
 
Any CAM 42% 
Oneschuk et al., 1998 
Alberta 
Palliative cancer 
patients (N=143) 
In-person 
interview 
Any CAM, minus 
diets, mind-body 
therapies 
 
37% 
Balneaves et al., 1999 
Manitoba 
Breast cancer (N=52) Self-administered 
questionnaire 
 
Any CAM 67% 
Nam et al., 1999 
Ontario 
Prostate cancer 
(N=232) 
Self-administered 
questionnaire 
Vitamins, 
minerals, herbs, & 
supplements 
 
33% 
Warrick et al., 1999 
Ontario 
Head & neck cancer 
(N=200) 
In-person 
interview 
 
Any CAM 39% 
Boon et al., 2000 
Ontario 
Breast cancer 
(N=422) 
Self-administered 
questionnaire 
 
Any CAM 67% 
Edgar et al., 2000 
Quebec 
Breast cancer 
(N=156) 
In-person 
interview 
 
Any CAM 72% 
Bold & Leis, 2001 
Saskatchewan 
Families with a child 
with cancer (N=44) 
Telephone 
interview 
 
Any CAM 36% 
Lesperance et al., 2002 
British Columbia 
 
Breast cancer (N=90) Historical cohort Mega-dose 
vitamins/minerals 
n/a 
Tough et al., 2002 
Alberta 
Colorectal cancer 
(N=871) 
Self-administered 
questionnaire 
 
Any CAM 49% 
Boon et al., 2003 
Ontario 
Prostate cancer 
(N=534) 
Self-administered 
questionnaire 
 
Any CAM 30% 
Eng, et al., 2003 
British Columbia 
Prostate cancer 
(N=451) 
Self-administered 
questionnaire 
Any CAM 39% 
McKay et al., 2005 
Nova Scotia 
Gynaecologic cancer Self-administered 
questionnaire 
Any CAM 76% 
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Only two articles discussed the use of CAM in pediatric cancer populations, with a reported prevalence 
of approximately 41%.52, 59 The remaining studies all focused on CAM use among adult cancer patients. 
Prevalence values ranged from 27 – 76%, with lowest usage among prostate cancer patients and highest 
usage among breast and gynaecologic cancer patients. The average percentage of CAM use across all 
adult studies was found to be approximately 46%, which is similar to other studies conducted 
elsewhere.74-91 
 
Although the particular nature of CAM was not always specified or defined in the studies reviewed, those 
studies which did include a definition of CAM for their respective study, defined CAM as therapies or 
approaches to the treatment and/or care of cancer that is not included in standard conventional cancer 
treatments used in North America, such as, surgery, chemo-, hormone-, and radiotherapy. Reported CAM 
therapies and modalities ranged widely across studies, although several themes became apparent. Almost 
all studies reported use of therapies in each one of the NCCAM’s classification domains, as discussed 
previously; however, when the studies were organized by study sample (i.e., female, male, and children), 
key differences in CAM use emerged. It was observed that within cancers that affect female patients (i.e., 
breast and gynaecologic), the most common CAM therapies utilized were mind-body or psychological 
therapies, specifically, meditation, relaxation therapies, support groups, and prayer.54, 57, 58, 64 In contrast, 
studies documenting CAM use in prostate cancer, which affects solely the male population, found that 
biologically-based therapies were most prevalent, most notably, vitamins (e.g., vitamins C and E), 
minerals (e.g., selenium), and herbal remedies and/or supplements (e.g., saw palmetto).55, 62, 63 
Interestingly, in the pediatric cancer population, use of both psychological and biological CAM therapies 
were highly prevalent.52, 59 Such differences may be the result of the various motives and reasons for 
patients with a cancer diagnosis to use CAM therapies. 
 
While the use of CAM therapies among cancer patients in Canada is quite varied, the reasons for using 
CAM are rather focused. In addition to wanting to exhaust all treatment possibilities,52, 61 the most 
frequently cited reasons by cancer patients for using CAM include, boosting the immune system,52, 59, 63 
improving general well-being and quality of life,53, 59, 63, 64 and treating the cancer itself, either to provide 
a cure, slow disease progression, or to prevent recurrence.52, 53, 56, 63 In addition, cancer patients 
commonly chose to use CAM therapies in order to provide symptomatic relief from conventional 
medicine,56, 59 and to utilize a self-perceived more natural and holistic approach to their cancer care.52, 61 
Recently, evidence from research in psycho-oncology has demonstrated that many cancer patients choose 
to use CAM in order to increase personal control over their disease status and treatment decision-
making.92, 93 Alternatively, reasons for non-use are centred around the lack of personal knowledge and 
high quality scientific research surrounding CAM therapies,52, 56, 63 as well as the lack of support from 
conventional healthcare practitioners.52 
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In addition to determining the prevalence of CAM use among cancer patients, Canadian researchers have 
been quite active in identifying variables predictive of CAM use within this population. Using multiple 
logistic regression analyses, several studies have identified key predictor variables which can be 
organized into three distinct variable themes: socio-demographics, medical characteristics, and 
personality traits. Within the category of socio-demographics, younger age,56, 57, 61 female sex,61 higher 
education,54, 56, 57 and higher income56, 57 have all been significantly associated with CAM use among 
cancer patients. Medical characteristics correlated with CAM use include, having recurrent or advanced 
disease status56, 61 and having received conventional cancer treatments (e.g., chemo- and hormone 
therapy).57, 61, 62 Personality traits that have been shown to be predictive of CAM use include, a proactive 
role in treatment decision-making54, 57 and participating in support groups.57, 62 Of importance is the fact 
that these results have been validated in other studies of cancer patients conducted elsewhere in the 
world.94-99 However, despite such overwhelming evidence in identifying the individuals most likely to 
use CAM for their cancer care, studies continue to contradict each other in terms of predictor variables. 
Recently, in a study of gynaecologic cancers, McKay et al., did not find any significant differences in 
patient characteristics between CAM users and non-users.64 As a result, researchers and clinicians must 
be vigilant in scrutinizing such study findings and cautious when applying such results in practical 
settings. 
 
2.4 CAM Use in Chinese Cancer Patients 
In recent years, the use of CAM in cancer patients of a specific ethno-cultural group has been studied by 
various researchers worldwide. This statement holds true for Chinese cancer patients as well. Nine 
publications assessing CAM use among Chinese cancer patients were retrieved from a MEDLINE search 
(1996 – 2005) of the literature.100-108 The observation that only two of the nine publications were 
published in the 1990s testifies that research in this field is spurring much interest among 
investigators.102, 107 The majority of the studies reviewed were conducted in the United States with 
Chinese-American cancer patients.102-105, 108 Taiwan106, 107 and Hong Kong100 were the sites of other 
studies. Surprisingly, only one study was conducted in China.101 For the most part, studies had a cross-
sectional design and used structured or semi-structured measurement instruments. Contrasting Canadian 
studies, which primarily utilized a mail survey for data collection, studies with Chinese cancer patients 
predominantly implemented in-person interviews.101-103, 106, 107 Such differences between these two study 
populations highlights the importance of cultural sensitivity and understanding that study methodologies 
must be customized to the population under study. The key data from these studies are summarized in 
Table 2.2.  
 
In contrast to their Canadian counterparts which studied specific cancer populations (i.e., breast, 
colorectal, prostate, etc.), the vast majority of studies in Chinese cancer patients were conducted in 
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patients with various cancers and tumour sites.102, 103, 106-108 Three studies were conducted with breast 
cancer patients100, 101, 105 and only one with prostate cancer patients.104 Prevalence of CAM use ranged 
from 25 – 98%. The average prevalence across all studies with adult Chinese cancer patients was 
determined to be 69%, much greater than the prevalence observed among Canadian cancer patients 
(46%). 
 
Table 2.2 – Studies investigating CAM use in Chinese cancer patients. 
Author, Year, & Site Study Sample Method CAM Therapies Prevalence 
Liu et al., 1997 
Taiwan 
Various cancers 
(N=100) 
In-person 
interview 
 
TCM herbal remedies 64% 
Gotay et al., 1999 
United States 
Various cancers 
(N=136) 
In-person 
interview 
 
Any CAM 36% 
Lee et al., 2000 
United States 
Breast cancer 
(N=82) 
Telephone 
interview 
 
Any CAM 41% 
Maskarinec et al., 2000 
United States 
Various cancers 
(N=96) 
Self-administered 
questionnaire 
 
Any CAM 25% 
Lee et al., 2002 
United States 
Prostate cancer 
(N=109) 
Telephone 
interview 
 
Any CAM 28% 
Kakai et al., 2003 
United States 
Various cancers 
(N=42) 
In-person 
interview 
 
Any CAM N/A 
Abdullah et al., 2003 
Hong Kong 
Breast cancer 
(N=352) 
Self-administered 
questionnaire 
 
Any TCM modalities 28% 
Li-chun & I-chuan, 2004 
Taiwan 
Various cancers 
(N=137) 
In-person 
interview 
 
Any TCM modalities 61% 
Cui et al., 2004 
China 
Breast cancer 
(N=1065) 
In-person 
interview 
TCM, supplements, 
physical exercises, 
support groups 
98% 
 
Although rarely defined in a clear, concise manner, examples of CAM therapies cited in studies with 
Chinese cancer patients were wide-ranging, much like in the Canadian studies. It was interesting to note 
that there was a distinct difference in the definition of CAM between studies conducted in the United 
States and those conducted elsewhere. Articles from the United States surveyed patients about any CAM 
therapies, categorizing TCM as a CAM modality, rather than a distinct medical system.102-105, 108 In 
striking contrast, the publications from Asia had a much narrower scope of CAM and generally focused 
on TCM and specific modalities within this system (e.g., acupuncture, herbal remedies, qi-gong).100, 101, 
106, 107 Chinese cancer patients commonly chose biologically-based TCM therapies, including herbal 
remedies and supplements for their cancer care. Abdullah et al., reported that 45%, 14%, and 44% of 
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CAM users with breast cancer ingested Ganoderma lucidum, ginseng, and shark cartilage, 
respectively.100 This result was confirmed in an another sample of breast cancer patients in a study by Cui 
et al., however, more patients in this sample (62%) reported using ginseng.101 In addition, psychological 
therapies (e.g., support groups, spirituality) and mind-body therapies (e.g., qi-gong, tai chi) were used 
much less frequently by Chinese cancer patients. For example, in two separate studies, psychological or 
mental support was used by 13% and 16% of patients.104, 105 Furthermore, Maskarinec et al., observed 
that only 4% of cancer patients participated in support groups as part of their cancer care.108 With respect 
to mind-body therapies, studies by Li-chun & I-chuan and Maskarinec et al., reported that among 
Chinese cancer patients only 2% and 4%, respectively practiced qi-gong or tai chi as part of their 
treatment regimen.106, 108 In striking contrast to the studies documenting CAM use in Canadian cancer 
patients, use of vitamins and/or minerals by Chinese cancer patients was almost non-existent with 
prevalence values ranging from 0 – 6%.101, 104, 105 Of great interest was the minimal use of acupuncture by 
patients as well. Among studies which documented acupuncture, use ranged from 0 – 8% within this 
population.101, 104, 106, 108 It is important to consider that such a surprising finding may be attributed to 
Chinese patients’ perception of what therapies constitute CAM. Acupuncture has been in existence for 
greater than 2,500 years and is deeply rooted in Chinese culture and as such may be viewed as 
mainstream and not as “complementary” or “alternative”.109 
 
As well as wanting to try all treatment regimens,107 Liu et al., and Cui et al., identified that Chinese 
cancer patients most often chose CAM as a means to treat their cancer directly, alleviate symptoms 
associated with cancer and its conventional treatment, and to increase strength and enhance immunity.101, 
107 Furthermore, Abdullah et al., determined that other reasons for CAM use included the belief that 
simultaneous use of conventional medicine and CAM is more effective than using either one alone 
(51%), persuasion by family members and/or friends (48%), belief that CAM can improve general health 
status (42%), and CAM use enabled patients to assume a more proactive role in treatment decision-
making (31%).100 Although the above-reported results are comparable to results obtained with Canadian 
cancer patients, it is interesting to note that results on the reasons for CAM use among Chinese cancer 
patients were all conducted in Asia and none in North America. Chinese-Americans and Chinese-
Canadians may be different from the Chinese population in Asia with respect to cultural characteristics 
and beliefs about conventional medicine and CAM. This may ultimately result in markedly different 
reasons for choosing to use CAM for cancer care. 
 
Factors associated with CAM use among Chinese cancer patients were similar to those observed in 
Canadian cancer patients. The most frequently cited variables predicting CAM use included, younger 
age,100-102, 105, 107 higher education,100-102, 104 higher income,100, 101 advanced disease/metastasis,101, 106 and 
having received some form of conventional cancer treatment (e.g., chemo-, hormone-, radiotherapy).101, 
104, 106 Other determinants of CAM use among Chinese cancer patients included the following: female 
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sex,106 being married,101 attending support groups,105 influence from family members and/or friends,104 
experiencing symptoms related to cancer or its treatments,106 and religious participation.102, 106 
 
2.5 Chinese Attitudes Towards Conventional Medicine and TCM 
In helping to understand the rates of CAM use among Chinese cancer patients, it is important to 
understand Chinese patients’ beliefs surrounding both conventional medicine and TCM. Literature in this 
area is scant, with only four relevant studies published in the past decade.110-113 Studies will be discussed 
separately as each utilized different research methodologies and document specific issues relating to 
Chinese beliefs and attitudes towards conventional medicine and TCM.  
 
Using qualitative analysis from semi-structured focus groups with 29 Chinese patients from Hong Kong, 
Lam, observed that patients’ choice of medicine, whether conventional or TCM, was largely based on the 
type of illness experienced by the patient.110 Patients reported that TCM was effective for milder 
illnesses, such as coughs and colds and that TCM produced fewer side effects as opposed to conventional 
medicine. Furthermore, patients expressed the notion that TCM was better at curing disease. Many 
patients stated that TCM was used mainly as a supplement to conventional medicine in order to treat side 
effects associated with conventional medicine and to “clear the root of disease.” TCM was seldom used 
in isolation, except in situations where patients perceived conventional medicine as failed or as an act of 
desperation. Not all experiences with TCM were positive, and several patients stated that TCM was slow-
acting and inconvenient due to the fact that herbs needed to be boiled and it would take several visits to a 
TCM practitioner to be cured. The general consensus among focus groups was that patients would elicit 
the aid of conventional medicine practitioners first, because of the speed in controlling symptoms and 
convenience of conventional medicine, and then consult a TCM practitioner to help rid the body of 
disease and treat the side effects of conventional medicine. 
 
Chan et al., studied 503 Hong Kong Chinese patients in order to investigate Chinese healthcare beliefs.111 
Using a structured, self-administered questionnaire, the researchers identified three specific clusters of 
patients, each with specific attitudes towards conventional medicine and TCM. The first cluster consisted 
of mainly older female patients of lower socioeconomic status (SES) with a greater proportion of chronic 
disease and time spent in hospital. This cluster was found to have the lowest trust in conventional 
medicine. The second cluster, which was comprised of younger male patients with higher education and 
income who have experienced higher proportions of acute illness, had the highest trust in conventional 
medicine and the lowest trust in TCM. Finally, the third cluster consisted of younger male patients with 
low SES and high proportions of chronic disease. This cluster had high trust in both conventional 
medicine and TCM. Although no plausible explanations for the results obtained were provided by the 
researchers, this study clearly highlighted the fact that the Chinese population is not a homogenous 
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sample and differences in healthcare choices are strongly influenced by socio-demographic and medical 
characteristics. 
 
In another study, Simpson, explored the beliefs regarding diet in the context of TCM in a sample of 20 
Chinese breast cancer patients in Hong Kong.112 Within Chinese culture, there is a philosophical link 
between diet and health. Chinese diet therapies emphasize food that assists the body’s ability to dispel 
disease and provide nourishment, thus regulating the harmonic balance between yin/yang. Because diet is 
so intrinsically linked with TCM, food and medicines (i.e., herbal remedies) are classified according to 
the same principles. Medicine is used to treat disease, and food is used for health. Thus, food can be used 
as medicine, but medicine cannot be used as food. Food, when used in the context of TCM to treat breast 
cancer is thought to increase weight, prevent nausea and vomiting, boost cell counts, and to modify mood 
and pain. However, patients and their families expressed much confusion as to what foods should or 
should not be eaten when treating someone with breast cancer. Respondents viewed conventional 
medicine’s approach to treating cancer as fighting “poison against poison” and viewed TCM as a more 
holistic approach. In addition to using food, specific TCM modalities, such as qi-gong, were believed to 
improve blood circulation and enhance metabolism, thus helping the patient recover from “powerful” 
conventional treatments and to prevent recurrence. Furthermore, many patients and their families stated 
that some forms of conventional medicine were unacceptable and thus, TCM would be used as a first line 
of treatment against the cancer. For example, avoiding surgery and other forms of body disfigurement 
was of paramount importance due to the emphasis placed on young unmarried women being perfect, and 
thus more desirable marriage partners in Chinese culture.  
 
In the final study reviewed, Liang, observed and interviewed 34 caregivers of children with cancer in 
Taiwan to assess the influence of culture on care practices.113 One of the themes identified was the 
attitudes of caregivers towards conventional medicine and TCM. Congruent with the above-mentioned 
studies, respondents believed that conventional medicine had a strong basis of scientific knowledge and 
would be most useful for treating childhood cancer, thus a practitioner of conventional medicine would 
always be visited first. Most caregivers reported using some form of TCM (e.g., food, herbal remedies, 
prayer) to help the child by increasing their strength and easing the side effects from conventional 
medicine. Although the majority of caregivers did not disclose their use of TCM for fear that the 
physician would disprove, they believed that the role of TCM was to support conventional treatments, 
thus providing the best chance for cure. 
 
Overall, these studies pointed out that a considerable portion of Chinese patients believed in and 
encouraged the use of TCM as a complement to conventional medicine for the management of disease 
symptoms and to maintain overall health and well-being. Of interest was the fact that many Chinese 
patients did not communicate their use of TCM to their conventional medicine practitioners, similar to 
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the findings in Eisenberg et al., landmark study in which 72% of CAM users did not discuss their choice 
of therapies with their physicians.114 Among Chinese patients, reluctance to tell a physician that 
TCM/CAM therapies are being sought and utilized is due to patients’ fear that their physician will “lose 
face” and is thus avoided.115 
 
2.6 Measuring Acculturation in Health Research 
Acculturation as an independent variable affecting health has been investigated by several researchers, 
especially in examining the association between acculturation and health service utilization.116-118 
Acculturation refers to the process by which an individual’s attitudes, beliefs, and behaviours become 
more congruent with that of the host or dominant society.119 
 
Existing scales of acculturation measurement fall within two broad categories: single-item proxy 
measures and multi-dimensional scales. A third type consists of combination of the two. Within Chinese, 
and other Asian populations, single-item proxy measures, such as duration of residence, place of birth, 
generation, education, and language use/proficiency have been used to assess health service utilization 
relating to cancer.120-125 Results using such single-item proxy measures, however are variable and 
inconsistencies are evident when comparing studies investigating acculturation. For example, in the study 
conducted by Hislop et al., Chinese patients who had a longer duration of residence in Canada were 
significantly more likely to have had a Pap test in the previous two years (p < 0.027).125 This relationship 
however was not found in the study conducted by Chen and Bakken, where degree of acculturation, as 
measured by language and social preferences, was not associated with perception of health service access 
and knowledge of breast cancer risks (p = 0.11, p = 0.091).120 When used individually or in combination, 
single-item proxy measures offer researchers greater flexibility in exploring the relationships between 
health effects and separate dimensions of acculturation, but may provide conflicting results.126 
 
Despite wide-spread use of single-item proxy measures, they have been criticized for their lack of depth 
and providing only a superficial measure of acculturation. As a result, several multi-dimensional scales 
have been developed. With respect to Asian populations, the Suinn-Lew Asian Self-Identity 
Acculturation (SL-ASIA) scale is commonly used and its reliability and validity have been verified.127-130 
The SL-ASIA is a 21-item instrument which includes the following categories: generation, language 
use/fluency, identity, friendship circles, and attitudes. A higher score indicates increased degree of 
acculturation. Using the SL-ASIA, Tang et al., observed that among Chinese-American women over 60 
years of age, increased acculturation predicted having had a mammography and clinical breast 
examination at least once (p < 0.05); however, no effect was seen with adherence to breast cancer 
screening behaviour.131 
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Capturing the acculturation level of individuals is a difficult task and is complicated by other factors 
including education, income, SES, and geography and it is evident that results obtained in studies are 
greatly dependent on the choice of proxy measure or instrument scale. As such, researchers are calling 
for the development of refined scales which will provide consistent findings.119, 126 
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3. STUDY METHODOLOGY 
This study represents the first portion of a multi-phase, three-year study. Within the context of this larger 
study, this research (Phase Ia) provided an estimate of TCM/CAM use for cancer care among newly 
diagnosed Chinese cancer patients. Chinese cancer patients who self-identify in Phase Ia by filling a 
contact information form will be enrolled in the Phase Ib portion of the study and will participate in a 45-
minute in-person interview collecting more detailed information, including beliefs surrounding cancer 
and TCM/CAM, satisfaction with both conventional medicine and TCM/CAM, and quality of life. One 
year later, interviewed patients who have given permission to be contacted again by the researchers will 
receive a telephone call for a follow-up interview (Phase II) in order to assess any changes in their use of 
TCM/CAM for their cancer care. 
 
3.1 Design and Setting 
This cross-sectional study involved all Chinese (Mandarin-, Cantonese-, or English-speaking) cancer 
patients who attended the Vancouver Cancer Centre (VCC) and the Richmond Community Oncology 
Centre (RCOC) for the first time between 13 March and 19 May 2006. The VCC is a full service cancer 
center offering several types of cancer therapies, such as chemo- and radiotherapy, with the exception of 
surgery. The RCOC provides systemic chemotherapy. In 2004, the VCC admitted approximately 5,258 
new patients, of whom approximately 780 (15%) were identified as Chinese. The VCC’s catchment area 
is estimated at two million people. At the RCOC, 40% of the patients are reported to be of Chinese 
origin. The cities of Richmond, Vancouver, and Burnaby, which have the highest proportion of Chinese 
population in BC, all fall within the Vancouver and Richmond cancer facilities’ catchment area. 
 
3.2 Sample Characteristics 
All newly diagnosed Chinese cancer patients who attended the Vancouver and Richmond cancer facilities 
for treatment were invited to participate in a five-minute structured questionnaire upon their presentation 
at the admissions desk (Vancouver) or during their first oncology education session (Richmond). Chinese 
patients were defined as those who identified themselves as having family origins from China, Hong 
Kong, or Taiwan. Inclusion criteria were as follows: a) all tumour sites and treatment regimens, b) ≥ 18 
years of age, c) Mandarin-, Cantonese-, and/or English-speaking, and d) well enough to participate. 
Based on clinician feedback at the VCC, many Chinese speaking patients have expressed confidence in 
the care provided to them and they value contact in their own language. 
29 
Estimates have the total number of eligible participants at 900 for the year 2006, based on 780 new 
admissions per year at the VCC and based on at least 120 Chinese cancer patients who undergo 
chemotherapy treatment at the RCOC. These estimates factor out those patients not offered treatment, too 
ill to participate, palliative at diagnosis, and those who return to their country of origin for treatment. A 
sample size of 87 will provide 95% confidence with 10% absolute error in the estimated prevalence of 
TCM/CAM use among patients.132 The sample size calculation assumes that the population proportion 
under the null hypothesis, that is, the proportion of the newly diagnosed Chinese cancer patients who use 
TCM/CAM is 50%. 
 
3.3 Measurement Instrument 
Given this new area of investigation, virtually no tested and established research-derived measurement 
instruments were available and as such a structured questionnaire was used for data collection. The 
instrument was based on previous studies investigating the use of CAM and results from a study 
assessing CAM use among cancer patients across six Canadian provinces by Leis et al., (unpublished), as 
well as on expert reviews. The bilingual (Chinese and English) questionnaire consisted of 15 closed-
ended questions and was designed to assess the prevalence of TCM/CAM use while collecting basic 
information on medical characteristics, socio-demographics, and cultural influences (see Appendix A). 
The instrument was devised using uncomplicated language due to anticipated communication barriers 
with patients (e.g., fluency in English, education levels). Questions take the form of “yes/no” and “check 
all that apply.” To make the translated instrument culturally appropriate, terms that are preferred and 
commonly used by the target population were utilized. If such a procedure was not adhered to, the 
translation may be foreign to the target population and accurate responses may not have been obtained.133 
The questionnaire focused on four domains to investigate the research objectives: a) prevalence of 
TCM/CAM use (use before and after cancer diagnosis, specific modalities used), b) medical 
characteristics (type of cancer, conventional treatment(s) received, disease duration), c) socio-
demographics (age, sex, marital status, income, education), and d) heritage consistency and cultural 
characteristics (survey language, place of birth, parents’ place(s) of birth, language spoken at home, 
living situation). The questionnaire was designed to be self-administered and completed within five 
minutes.  
 
To ensure that the maximum number of eligible patients were provided the opportunity to participate in 
the study, the questionnaire was translated from English into Chinese (one written language for both 
Mandarin and Cantonese). A common and highly recommended procedure known as “back translation” 
was used.134, 135 In this procedure, a translator renders the instrument into the target language. A different 
translator then translates the resulting interpretation back into the original language. Items with apparent 
discrepancies between the two translations were then modified. Evidence demonstrates that translations 
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are of a higher quality when undertaken by at least two independent translators.136 The multiple 
translations allow for the detection of errors due to the language knowledge of a translator and divergent 
interpretations of ambiguous items in the original measurement instrument.135, 137  
 
3.4 Study Variables 
As discussed previously, the study variables selected for inclusion in the measurement instrument were 
the result of previous research and expert reviews. Study variables are detailed in Table 3.1 according to 
their domain (socio-demographic, medical, cultural, TCM/CAM use), type (nominal, ordinal, interval), 
and their classification according to Andersen and Newman’s model of health service utilization 
(predisposing, enabling, illness level). Variables classified in the socio-demographic and medical 
characteristics domains, as well as use of TCM/CAM before being diagnosed with cancer have all been 
investigated and researchers have found significant associations between these variables and TCM/CAM 
use in cancer patients, as discussed in Chapter 2. Novel to the knowledge base in this field of research are 
the variables assessing cultural factors associated with TCM/CAM (survey language, place of birth, 
parents’ place(s) of birth, language spoken at home, living situation). Due to the complexity of measuring 
culture and study feasibility, these variables were selected to provide a proxy measure of patients’ degree 
of acculturation. The cultural characteristics domain, which could have included several other variables, 
for example, attitudes towards TCM/CAM and conventional medicine, as well as beliefs surrounding the 
causes of cancer was limited to a maximum of four variables, which were compiled in a structured format 
in order to minimize the amount of time required for completion of the questionnaire. Study variables 
were then re-classified for analysis as described in Table 3.2. 
 
3.5 Procedure 
All eligible patients were identified at their first visit to their respective cancer centre and were provided 
a bilingual copy of a letter describing the study and the measurement instrument. Return of the 
questionnaire occurred anonymously in labeled boxes near the admission desk within each cancer centre. 
Questionnaires were coded and submission boxes were emptied regularly by a research assistant in order 
to maintain anonymity. A bilingual research assistant (Vancouver) and clinic nurses (Richmond) ensured 
that the questionnaires were distributed with the other standard forms to be completed as per BCCA 
policy and were available for any questions patients might have had. 
 
Primary coordination of the study occurred at the University of Saskatchewan and a Chinese Community 
Advisory Committee was established at the BCCA’s Sociobehavioural Research Centre to advise the 
researchers throughout the study stages and to collaborate in patient recruitment, data collection, and 
dissemination of results that may have been sensitive to the community. This committee included 
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members of the Canadian Cancer Society, Taiwanese Canadian Cultural Society, Richmond Hospital, 
Success, Provincial Health Service Authority, and Chinese cancer patients and caregivers.  
Table 3.1 – Study variables collected with the measurement instrument. 
Domain Variable Type Model Factor 
Age Interval Predisposing 
Sex Nominal Predisposing 
Marital Status Nominal Predisposing 
Education Level Ordinal Predisposing 
Socio-demographics 
Household Income Ordinal Enabling 
Cancer Type Nominal Illness Level 
Conventional Therapies Received Nominal Illness Level 
Medical 
Disease Duration Interval Illness Level 
Survey Language Nominal Predisposing 
Place of Birth Nominal Predisposing 
Parents’ Place(s) of Birth Nominal Predisposing 
Language Spoken at Home Nominal Predisposing 
Cultural 
Living Situation Nominal Predisposing 
TCM/CAM Use Before Diagnosis Nominal Enabling 
TCM/CAM Use After Diagnosis Nominal Outcome 
Prevalence of TCM/CAM 
Type(s) TCM/CAM Used After Diagnosis Nominal N/A 
 
3.6 Data Analysis 
Analyses were performed with Statistical Package for the Social Sciences (SPSS, Windows build 13, 
SPSS Inc., Chicago, IL). All hypothesis tests were two-sided and the type I error rate or significance 
level set at α = 0.05. Based on the power calculation in comparing two binomial proportions using a two-
sided test with independent samples, this study had 37% and 29% power to detect a statistically 
significant difference between acculturated and less acculturated patients and male and female 
TCM/CAM users, respectively.138 
 
1. To estimate the prevalence of TCM/CAM use among Chinese cancer patients upon admission 
to the BCCA. The point prevalence among newly diagnosed Chinese cancer patients was estimated 
with descriptive statistics by tabulating the number of patients who reported using TCM/CAM since 
being diagnosed with cancer (question #8). The types of TCM/CAM modalities and therapies used 
by patients were also identified. TCM/CAM users and non-users were compared across all study 
variables, except type of TCM/CAM used with Χ2-tests (or Fisher’s Exact test) and t-tests, 
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depending on the type of the variable. A multiple logistic regression model was used to identify 
predictor variables of TCM/CAM use as discussed in the next section. It was hypothesized that 
TCM/CAM users and non-users would not differ significantly across all study variables.  
 
Table 3.2 – Re-classified variables for analysis. 
Category Original Variables New Variables 
Place of birth 1. Canada 
2. China; Hong Kong; Taiwan; Other 
1. Canada 
2. Outside Canada 
 
Parental place(s) of 
birth 
1. Canada 
2. China; Hong Kong; Taiwan; Other 
1. Canada 
2. Outside Canada 
 
Language spoken 
at home 
1. English; French 
2. Cantonese; Mandarin; Taiwanese; Other 
 
1. Official language 
2. Non-official language 
Martial status 1. Single; Widowed; Divorced 
2. Married; Common law 
1. Single 
2. Married 
 
Living situation 1. Alone; Spouse; Parents; 
Children/grandchildren 
2. With friends; Other relatives 
 
1. With immediate family 
2. With extended family 
Education level 1. Elementary; Some high school 
2. High school diploma; Technical/community 
college; Some university; University degree; 
Post-graduate training 
 
1. < High school diploma 
2. ≥ High school diploma 
Income 1. < $20, 000; $21,000-$40,000 
2. $41,000-$60,000; $61,000-$80,000; >$81,000 
1. ≤ $40,000 
2. > $40,000 
 
2. To identify socio-demographic, medical, and cultural characteristics predictive of TCM/CAM 
among Chinese cancer patients. In order to identify patient characteristics based on socio-
demographics, medical characteristics, and cultural influences predictive of TCM/CAM use since 
being diagnosed with cancer, multiple logistic regression was utilized on all study variables, except 
type of TCM/CAM used. After an initial regression analysis of all variables, the variables for age, 
sex, and cancer type and variables with p < 0.25 were then selected and inputted into another 
regression analysis to obtain the final predictive model. It was hypothesized that no study variables 
would significantly predict the use of TCM/CAM among Chinese cancer patients. Pertinent 
information relating to theory and application of logistic regression is discussed below. 
  
Logistic regression is a form of regression which is used when the dependent variable (i.e., use of 
TCM/CAM after diagnosis of cancer) is dichotomous and the independent variables are of any type (i.e., 
nominal, ordinal, interval, or ratio).138, 139 Logistic regression can be used to predict a dependent variable 
on the basis of independent variables and to determine the percent of variance in the dependent variable 
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explained by the independent variables, rank the relative importance of independent variables, assess 
confounding effects, and statistically test interaction effects. Logistic regression applies maximum 
likelihood estimation after transforming the dependent variable into a logit variable, which is the natural 
log of the odds of the dependent variable occurring or not. Maximum likelihood estimation seeks to 
maximize the log likelihood, which reflects how likely it is (i.e., the odds) that the observed values of the 
dependent variable may be predicted from the observed values of the independent variables.139 Maximum 
likelihood estimation is an iterative algorithm which starts with an initial arbitrary estimate of what the 
logit coefficients should be and the algorithm determines the direction and size change in the logit 
coefficients which will increase the log likelihood. After this initial function is estimated, the residuals 
are tested and a re-estimate is made with an improved function, and the process is repeated until 
convergence is reached (i.e., until the log likelihood does not change significantly). In this way, logistic 
regression estimates the probability of a certain event occurring. It is important to understand that logistic 
regression calculates changes in the log odds of the dependent variable, not changes in the dependent 
variable itself. 
 
3. To investigate differences in TCM/CAM and other characteristics between acculturated and 
less acculturated patients. As with the comparison between TCM/CAM users and non-users, 
differences in patient characteristics among acculturated and less acculturated patients were explored 
with the appropriate significance tests [Χ2-tests (or Fisher’s Exact test) and t-tests]. In this analysis, 
less acculturated patients were those defined as being born outside of Canada and completing the 
Chinese version of the questionnaire. Using this combination of single-item proxy measures, allowed 
for the discrimination of patients who may have been born outside of Canada but immigrated at a 
very young age and were thus more acculturated to Western society as observed by their comfort in 
completing the English version of the questionnaire. Patients were compared across all study 
variables to determine if differences existed in the socio-demographic, medical, and cultural 
characteristics between the two groups. It was hypothesized that acculturated and less acculturated 
patients would not differ significantly across all study variables. 
 
4. To explore differences in patient characteristics among TCM/CAM users. In this subset 
analysis, male and female TCM/CAM users were compared with the appropriate significance tests 
[Χ2-tests (or Fisher’s Exact test) and t-tests] across all study variables to determine if differences 
existed in the socio-demographic, medical, and cultural characteristics, as well as the types of 
TCM/CAM therapies used between the two groups. It was hypothesized that male and female users 
of TCM/CAM would not differ significantly across all study variables. 
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3.7 Ethical Considerations 
Although the methodology employed for this study required much more in depth ethical considerations 
as opposed to other potential study procedures, such as mail surveys, the in-person recruitment strategy 
used in this study was implemented in order to maximize patient participation. Such procedures were 
utilized so as not to compromise the scientific validity of the research. As is evident in the literature 
surrounding research with Chinese populations, the preferred method for data collection revolves around 
personal contact with patients,101-103, 106, 107 and as such this methodology was employed. In addition, due 
to the fact this research targeted a specific ethno-cultural group, specific considerations for patient 
recruitment were employed in order to avoid any pitfall that might be related to racial profiling. This 
included having a research coordinator on staff at the BCCA clinic who facilitated the identification of 
eligible participants without having to rely on their physical characteristics. 
 
Patients received information about the study in a cover letter prior to completing the questionnaire and 
consent was obtained by the actual completion and submission of the questionnaire to either the research 
assistant or in one of the designated collection boxes. Study data, including completed questionnaires and 
analyses performed are now stored in a locked cabinet in the Department of Community Health & 
Epidemiology at the University of Saskatchewan for a minimum of five years under the responsibility of 
Dr. Anne Leis. This study was approved by the University of Saskatchewan Behavioural Research Ethics 
Board, the BCCA Research Ethics Board, and the Richmond Health Services Delivery Area Research 
Advisory Committee as a minimal risk study (see Appendix B). 
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4. RESULTS 
This study aimed to assess the use of TCM/CAM in a sample of newly diagnosed Chinese cancer patients 
in a major metropolitan centre in Canada. Univariate, bivariate, and multivariate analyses describe a 
heterogeneous population of patients who chose to use TCM/CAM for their cancer care. 
 
4.1 Patient Characteristics 
Univariate analyses were first used to describe the study population and their use of TCM/CAM. A total 
of 186 questionnaires were distributed and 91 were completed by patients yielding a response rate of 
48.9%. The final study population was comprised of 51 females (56.7%) and 40 males (43.3%). The 
mean age was 59.5 ± 15.9 years (range: 21 – 89). The majority of patients (63.7%) completed the 
questionnaire 
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Figure 4.1 – Distribution of cancer types in all patients. 
The “Other” category included 10 single incidence cancer types: appendix, bladder, bone, cervix, hearing 
tumour, leukemia, merkel nerve, pancreas, pituitary, and thyroid. 
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NHL, Non-Hodgkin’s lymphoma. 
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in Chinese. Most patients were married (70.8%), had a high school diploma or higher education (59.6%), 
and had a total annual income ≤ $40,000 (48.9%). Patients had a mean disease duration of 2.4 ± 2.2 
months at the time of the survey and the most frequent diagnoses were cancer of the breast (27.8%), 
colon/rectum (16.7%), and lung and prostate (7.8% each), as shown in Figure 4.1. The most common  
 
Table 4.1 – Patient socio-demographic characteristics. 
Variable All Patients  Users Non-users 
Age (years, mean ± SD) 59.5 ± 15.9 58.8 ± 15.7 60.2 ± 16.3 
 n (%) n (%) n (%) 
Sex    
   Male 38 (42.7) 11 (28.2) 27 (54.0) 
   Female 51 (57.3) 28 (71.8) 23 (46.0) 
Marital Status    
   Common law 2 (2.2) 0 (0.0) 2 (4.0) 
   Married 63 (70.8) 29 (74.4) 34 (68.0) 
   Single* 24 (27.0) 10 (25.6) 14 (28.0) 
Education Level    
   Elementary 17 (19.1) 8 (20.0) 9 (18.4) 
   Some high school 18 (20.2) 6 (15.0) 12 (24.5) 
   High school diploma 12 (13.5) 5 (12.5) 7 (14.3) 
   Technical/community college 12 (13.5) 4 (10.0) 8 (16.3) 
   Some university 13 (14.6) 7 (17.5) 6 (12.2) 
   University degree 12 (13.5) 7 (17.5) 5 (10.2) 
   Postgraduate training 4 (4.5) 2 (5.0) 2 (2.1) 
   Other 1 (1.1) 1 (2.5) 0 (0.0) 
Household Income    
   < $20,000 22 (24.4) 11 (27.5) 11 (22.0) 
   $21,000 - $40,000 22 (24.4) 12 (30.0) 10 (20.0) 
   $41,000 - $60,000 7 (7.8) 3 (7.5) 4 (8.0) 
   $61,000 - $80,000 6 (6.7) 1 (2.5) 5 (10.0) 
   > $81,000 3 (3.3) 0 (0.0) 3 (6.0) 
    Don’t know/Don’t want to answer 30 (33.3) 13 (32.5) 17 (34.0) 
* Includes widowed, separated, and divorced patients. 
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conventional treatment received was surgery (46.7%); however, 30.0% of patients reported not having 
had any conventional treatment at the time of the survey. With respect to patients’ cultural characteristics, 
just over half of the patients were born in China (51.1%). Patients were most commonly observed to be 
living with their partner/spouse (62.2%) and Cantonese was the language most often used at home 
(60.0%). Socio-demographic, medical, and cultural characteristics of study participants are shown in 
Tables 4.1 – 4.3. No information was collected on non-responders. 
 
Table 4.2 – Patient medical characteristics. 
Variable, n (%) All Patients Users Non-users 
Disease Duration (months, mean ± SD) 2.4 ± 2.2 2.8 ± 2.6 2.1 ± 1.8 
 n (%) n (%) n (%) 
TCM/CAM use before diagnosis 35 (38.9) 25 (62.5) 10 (20) 
TCM/CAM use after diagnosis 40 (100) n/a n/a 
Cancer Type    
   Breast 25 (27.8) 12 (30.0) 13 (26.0) 
   Colorectal 15 (16.7) 6 (15.0) 9 (18.0) 
   Liver 3 (3.3) 1 (2.5) 2 (4.0) 
   Lung 7 (7.8) 4 (10.0) 3 (6.0) 
   Melanoma 3 (3.3) 0 (0.0) 3 (6.0) 
   Naso-pharyngeal 3 (3.3) 2 (5.0) 1 (2.0) 
   Non-Hodgkin’s lymphoma 2 (2.2) 2 (5.0) 0 (0.0) 
   Oral 2 (2.2) 1 (2.5) 1 (2.0) 
   Ovary 2 (2.2) 1 (2.5) 1 (2.0) 
   Prostate 7 (7.8) 2 (5.0) 5 (10.0) 
   Stomach 2 (2.2) 0 (0.0) 2 (4.0) 
   Other 11 (12.2) 5 (12.5) 6 (12.0) 
   Unknown 8 (8.9) 4 (10.0) 4 (8.0) 
Conventional Therapies Received*    
   None 27 (30.0) 7 (17.5) 20 (40.0) 
   Chemotherapy 19 (21.1) 12 (30.0) 7 (14.0) 
   Radiotherapy 22 (24.4) 15 (37.5) 7 (14.0) 
   Surgery 42 (46.7) 19 (47.5) 23 (46.0) 
   Other 2 (2.2) 2 (5.0) 0 (0.0) 
* Due to multiple selection options on the questionnaire, percentages will not sum to 100%. 
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Table 4.3 – Patient cultural characteristics. 
Variable, n (%) All Patients Users Non-users 
Survey Language    
   English 33 (36.3) 11 (27.5) 22 (44.0) 
   Chinese 58 (63.7) 29 (72.5) 28 (56.0) 
Place of Birth    
   Canada 9 (10.0) 1 (2.5) 8 (16) 
   China 46 (51.1) 18 (45.0) 28 (56.0) 
   Hong Kong 27 (30.0) 16 (40.0) 11 (22.0) 
   Taiwan 4 (4.4) 4 (10.0) 0 (0.0) 
   Other 4 (4.4) 1 (2.5) 3 (6.0) 
Parental Place(s) of Birth*    
   Canada 3 (3.3) 0 (0.0) 3 (6.0) 
   China 68 (75.6) 33 (82.5) 35 (70.0) 
   Hong Kong 7 (7.8) 3 (7.5) 4 (8.0) 
   Taiwan 3 (3.3) 2 (5.0) 1 (2.0) 
   Other 1 (1.1) 0 (0.0) 1 (2.0) 
Language Spoken at Home    
   Cantonese 54 (60.0) 27 (67.5) 27 (54.0) 
   English 14 (15.6) 2 (5.0) 12 (24.0) 
   Mandarin 20 (22.2) 11 (27.5) 9 (18.0) 
   Other 2 (2.2) 0 (0.0) 2 (4.0) 
Living Situation*    
   Alone 11 (12.2) 3 (7.5) 8 (16.0) 
   With children/grandchildren 38 (42.2) 16 (40.0) 22 (44.0) 
   With other relatives 2 (2.2) 2 (5.0) 0 (0.0) 
   With parent(s) 3 (3.3) 2 (5.0) 1 (2.0) 
   With partner/spouse 56 (62.2) 25 (62.5) 31 (62.0) 
   Other 2 (2.2) 2 (5.0) 0 (0.0) 
* Due to multiple selection options on the questionnaire, percentages will not sum to 100%. 
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4.2 Frequency of TCM/CAM Use 
Forty patients (44.4%) reported having used TCM/CAM since their cancer diagnosis. Among users, the 
mean number of TCM/CAM modalities used was 1.75 (range: 1 – 5). The most frequently used 
TCM/CAM modalities included, herbal remedies (60.0%), vitamins/minerals (27.5%), and prayer 
(25.0%). The distribution of therapies used by male and female patients is shown in Figure 4.2. Thirty-
five patients (38.9%) reported using TCM/CAM prior to being diagnosed with cancer and of these 
patients, 10 (28.6%) stopped using TCM/CAM after being diagnosed. At the same time, of the 55 
patients who did not use prior TCM/CAM, 15 (27.3%) began using such modalities after being told of 
their diagnosis. 
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Figure 4.2 – Distribution of TCM/CAM therapies used by patients. 
The “Multiple” category consists of those patients who reported using > 1 TCM/CAM therapy. No 
significant differences in the type of TCM/CAM therapies used by male and female patients were 
observed in this sample. 
 
4.3 Comparison of TCM/CAM Users and Non-users 
Using Andersen and Newman’s model of health service utilization as a guide, important variables 
previously identified in earlier research were selected, categorized, and analyzed using bivariate methods 
to determine independent factors associated with TCM/CAM use within this population. Predisposing, 
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enabling, and illness level factors within the model were categorized into socio-demographic, medical, 
and cultural characteristics (see Table 3.1) and then analyzed as described in the following sections. 
 
Table 4.4 shows both socio-demographic factors significantly and not significantly associated with the 
use of TCM/CAM at any time since diagnosis. In terms of socio-demographic factors, female sex (OR 
2.988; 95% CI 1.225, 7.291; p = 0.015) was the only variable significantly associated with TCM/CAM 
use. Total household income demonstrated a trend towards significance, whereby patients with > $40,000 
annual income were less likely to use TCM/CAM (OR 0.304; 95% CI 0.085, 1.091; p = 0.081). Age, 
marital status and level of education were not significantly associated with TCM/CAM use. 
 
Table 4.4 – Bivariate analysis of socio-demographics and TCM/CAM use. 
Variable, n (%) t (df) OR 95% CI P-value 
Age (years) 0.415 (88) n/a n/a 0.679 
 X2 (df)    
Sex     
   Male REF    
   Female 5.959 (1) 2.988 1.225, 7.291 0.015 
Marital Status     
   Single* REF    
   Married 0.062 (1) 1.128 0.437, 2.909 0.804 
Education Level     
   < High school diploma REF    
   ≥ High school diploma 0.262 (1) 1.250 0.532, 2.937 0.608 
Household Income     
   ≤ $40,000 REF    
   > $40,000 3.526 (1) 0.304 0.085, 1.091 0.081 
   Don’t know/Don’t want to answer 0.571 (1) 0.698 0.275, 1.776 0.540 
Note: Unless a t-test was performed, for those variables where the OR is not available there is a null 
value in the 2 x 2 table. 
* Includes widowed, separated, and divorced patients. 
 
Table 4.5 shows the association of medical characteristics with TCM/CAM use. Use of TCM/CAM was 
significantly more prevalent among patients who used TCM/CAM prior to their diagnosis (OR 6.667; 
95% CI 2.595, 17.124; p < 0.001) and those patients who had received or were currently receiving 
chemo- or radiotherapy (OR 5.238; 95% CI 1.724, 15.919; p = 0.003). Type of cancer was not 
significantly associated with using TCM/CAM for cancer care. 
42 
 
Table 4.5 – Bivariate analysis of medical characteristics and TCM/CAM use. 
Variable, n (%) t (df) OR 95% CI P-value 
Disease Duration (months) -1.010 (36) n/a n/a 0.319 
 X2 (df)    
TCM/CAM use before diagnosis 16.890 (1) 6.667 2.595, 17.124 <0.001 
Cancer Type     
   Breast 0.177 (1) 1.220 0.483, 3.078 0.674 
   Colorectal 0.144 (1) 0.804 0.260, 2.485 0.704 
   Liver 0.155 (1) 0.615 0.0054, 7.042 1.000 
   Lung 0.496 (1) 1.741 0.366, 8.272 0.695 
   Melanoma 2.483 (1) n/a n/a 0.251 
   Naso-pharyngeal 0.621 (1) 2.579 0.225, 29.516 0.583 
   Non-Hodgkin’s lymphoma 2.557 (1) n/a n/a 0.195 
   Oral 0.026 (1) 1.256 0.076, 20.734 1.000 
   Ovary 0.026 (1) 1.256 0.076, 20.734 1.000 
   Prostate 0.775 (1) 0.474 0.087, 2.582 0.456 
   Stomach 1.636 (1) n/a n/a 0.501 
   Other 0.005 (1) 1.048 0.295, 3.720 0.943 
   Unknown 0.110 (1) 1.278 0.299, 5.463 1.000 
Conventional Therapies Received     
   None REF    
   Surgery 0.924 (1) 1.746 0.557, 5.469 0.399 
   Chemo/Radiotherapy 9.075 (1) 5.238 1.724, 15.919 0.003 
Note: Unless a t-test was performed, for those variables where the OR is not available there is a null 
value in the 2 x 2 table. 
 
Table 4.6 shows the association between cultural characteristics and use of TCM/CAM. Immigrant 
patients were more likely than those born in Canada to use TCM/CAM (OR 7.429; 95% CI 0.888, 
62.140; p = 0.040). Also, patients who reported speaking a non-official language most frequently at home 
were more likely to use TCM/CAM since their diagnosis (OR 6.000; 95% CI 1.257, 28.639; p = 0.018). 
Other cultural variables including survey language, parental place of birth, and living situation were not 
significantly associated with using TCM/CAM. Combining the variables for survey language and place 
of birth as a measure of acculturation did not significantly predict use of TCM/CAM in this study 
population (OR 2.071; 95% CI 0.850, 5.048; p = 0.107). 
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Table 4.6 – Bivariate analysis of cultural characteristics and TCM/CAM use. 
Variable, n (%) X2 (df) OR 95% CI P-value 
Survey Language     
   English REF    
   Chinese 2.605 (1) 2.071 0.850, 5.048 0.107 
Place of Birth     
   Canada REF    
   Outside Canada 4.500 (1) 7.429 0.888, 62.140 0.040 
Parental Place(s) of Birth     
   Canada REF    
   Outside Canada 2.483 (1) n/a n/a 0.251 
Language Spoken at Home     
   Official language REF    
   Non-official language 6.107 (1) 6.000 1.257, 28.639 0.018 
Living Situation     
   With immediate family REF    
   With extended family 1.297 (1) n/a n/a 0.438 
Note: Unless a t-test was performed, for those variables where the OR is not available there is a null 
value in the 2 x 2 table. 
 
4.4 Predictors of TCM/CAM Use 
Continuing from the bivariate investigation, the next step in analyzing the data was to perform a logistic 
regression analysis. Again, using Andersen and Newman’s model of health service utilization as a 
framework, all variables were entered into the regression model. Those variables reporting a significant 
association with TCM/CAM use were then re-entered into the regression analysis and a final predictive 
model was obtained. Logistic regression, a form of multivariate analysis differs from bivariate methods in 
that it allows for the identification of independent predictors of TCM/CAM use, while all other variables 
in the model are controlled for.  
 
Table 4.7 depicts the final logistic regression model predicting use of TCM/CAM since being diagnosed 
with cancer. This final parsimonious model exhibited a good fit with the data according to the Hosmer 
and Lemeshow Goodness-of-Fit Test (p = 0.800). The model included socio-demographic elements 
including age, sex, and total annual household income; medical characteristics, including previous use of 
TCM/CAM and cancer type; and place of birth as the sole cultural characteristic. Due to small counts 
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within the various cancer types, only the two most prevalent cancer types (breast and colorectal) were 
placed in the model, while the remaining cancer types were pooled into the “Other” category. Both prior 
use of TCM/CAM (p < 0.001) and being born outside of Canada (p = 0.030) predicted TCM/CAM use, 
whereas those patients with an annual income > $40,000 were significantly less likely to use TCM/CAM 
(p = 0.043). When controlling for all other variables in the model, patients who selected, “Don’t 
know/Don’t want to answer” in response to the income question on the questionnaire, were comparable 
to patients in the > $40,000 category, approaching significance in the logistic regression (p = 0.177). No 
effect modification or confounding was present in the multivariate analysis. 
 
Table 4.7 – Multivariate analysis of TCM/CAM use. 
Variable ORadj 95% CI P-value 
TCM/CAM use before diagnosis 30.721 6.166, 153.059 <0.001 
Age (years) 0.994 0.957, 1.033 0.775 
Sex    
   Male REF   
   Female 1.856 0.383, 8.994 0.442 
Household Income    
   ≤ $40,000 REF   
   > $40,000 0.122 0.016, 0.932 0.043 
   Don’t know/Don’t want to answer 0.365 0.084, 1.578 0.177 
Cancer Type    
   Breast REF   
   Colorectal 0.220 0.025, 1.961 0.175 
   Other 2.282 0.446, 11.681 0.322 
Place of Birth    
   China REF   
   Hong Kong 4.311 1.113, 16.699 0.034 
   Canada 0.049 0.003, 0.740 0.030 
   Other 4.169 0.530, 32.823 0.175 
 
4.5 Comparison of Acculturated and Less Acculturated Patients 
In continuing with the above-stated research objectives, the effect of culture or acculturation on the use 
of TCM/CAM in this population was explored. For the purposes of this study, less acculturated patients 
were defined as those patients who were born outside of Canada and completed the questionnaire in 
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Chinese, rather than in English. Bivariate analyses were guided by Andersen and Newman’s model of 
health service utilization and conducted as previously described.  
 
Table 4.8 shows the associations between study variables and acculturated and less acculturated patients. 
Fifty-seven patients (63.7%) were classified as less acculturated. There was no statistically significant 
difference in the use of TCM/CAM since being diagnosed with cancer between acculturated and less  
 
Table 4.8 – Comparison of acculturated and less acculturated patients. 
Variable Acculturated Less Acculturated t (df) OR 95% CI P-value 
Age (years, mean ± SD) 
 57.8 ± 17.1 60.5 ± 15.3 -0.77 (88) n/a 0.441 
Disease Duration (months, 
mean ± SD) 2.0 ± 1.5 2.8 ± 2.7 -1.15 (26) n/a 0.259 
 n (%) n (%) X2 (df)   
Current TCM/CAM 11 (33.3) 29 (50.9) 2.605 (1) 2.071 (0.850, 5.048) 0.107 
Prior TCM/CAM 14 (42.4) 21 (36.8) 0.274 (1) 0.792 (0.330, 1.900) 0.601 
Sex      
   Male 12 (36.4) 26 (46.4)    
   Female 21 (63.6) 30 (53.6) 0.860 (1) 0.659 (0.273, 1.594) 0.354 
Marital Status      
   Single* 13 (39.4) 11 (19.6)    
   Married 20 (60.6) 45 (80.4) 4.113 (1) 2.659 (1.018, 6.947) 0.043 
Education Level      
   < High school diploma 11 (34.4) 25 (43.9)    
   ≥ High school diploma 21 (65.6) 32 (56.1) 0.765 (1) 0.670 (0.273, 1.645) 0.382 
Household Income      
   ≤ $40,000 12 (36.4) 32 (56.1)    
   > $40,000 11 (33.3) 5 (8.8) 8.539 (1) 0.170 (0.049, 0.594) 0.003 
   Did not respond 10 (30.3) 20 (35.1) 0.314 (1) 0.750 (0.274, 2.055) 0.575 
      
Cancer Type      
   Breast 15 (45.5) 10 (17.5) 8.116 (1) 0.255 (0.097, 0.672) 0.004 
   Colorectal 4 (12.1) 11 (19.3) 0.775 (1) 1.734 (0.504, 5.962) 0.559 
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   Liver 0 (0.0) 3 (5.3) 1.797 (1) n/a 0.296 
   Lung 5 (15.2) 2 (3.5) 3.950 (1) 0.204 (0.037, 1.117) 0.095 
   Melanoma 1 (3.0) 2 (3.5) 0.015 (1) 1.164 (0.101, 13.346) 1.000 
   Naso-pharyngeal 0 (0.0) 3 (5.3) 1.797 (1) n/a 0.296 
   Non-Hodgkin’s lymphoma 0 (0.0) 2 (3.5) 1.184 (1) n/a 0.530 
   Oral 0 (0.0) 2 (3.5) 1.184 (1) n/a 0.530 
   Ovary 1 (3.0) 1 (1.8) 0.157 (1) 0.571 (0.035, 9.450) 1.000 
   Prostate 0 (0.0) 7 (12.3) 4.394 (1) n/a 0.044 
   Stomach 1 (3.0) 1 (1.8) 0.157 (1) 0.571 (0.035, 9.450) 1.000 
   Other 3 (9.1) 8 (14.0) 0.476 (1) 1.633 (0.402, 6.638) 0.740 
   Unknown 3 (9.1) 5 (8.8) 0.003 (1) 0.962 (0.214, 4.310) 1.000 
Conventional Therapies      
   None 12 (36.4) 15 (26.3)    
   Surgery 8 (24.2) 21 (36.8) 1.731 (1) 2.100 (0.690, 6.393) 0.188 
   Chemo/Radiotherapy 13 (39.4) 21 (36.8) 0.240 (1) 1.292 (0.463, 3.609) 0.624 
Parental Place(s) of Birth      
   Canada 3 (9.1) 0 (0.0)    
   Outside Canada 30 (90.9) 57 (100.0) 5.361 (1) n/a 0.046 
Language Spoken at Home      
   Official language 13 (39.4) 1 (1.8)    
   Non-official language 20 (60.6) 56 (98.2) 22.541 (1) 36.400 (4.47, 296.37) <0.001 
Living Situation      
   With immediate family 33 (100.0) 55 (98.2)    
   With extended family 0 (0.0) 1 (1.8) 0.596 (1) n/a 1.000 
Note: Unless a t-test was performed, for those variables where the OR is not available there is a null 
value in the 2 x 2 table. 
* Includes widowed, separated, and divorced patients. 
 
acculturated patients; however, the trend showed that less acculturated patients may be more likely to use 
TCM/CAM compared to acculturated patients (p = 0.107). Less acculturated patients were more likely to 
be married (p = 0.043), have parents born outside of Canada (p = 0.046), and speak a non-official 
language most often at home (p < 0.001), but were less likely to report an annual income of > $40,000 (p 
= 0.003). As well, cancer types more prevalent in less acculturated patients included tumours of the 
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breast (p = 0.004) and prostate (p = 0.044). The distribution of therapies used by acculturated and less 
acculturated patients is shown in Figure 4.3. A higher proportion of less acculturated patients used 
vitamins/minerals, acupuncture, tai chi, prayer, massage, and qi-gong; however, no significant 
differences were observed. 
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Figure 4.3 – Distribution of TCM/CAM therapies used by patients. 
The “Multiple” category consists of those patients who reported using > 1 TCM/CAM therapy. No 
significant differences in the type of TCM/CAM therapies used by acculturated and less acculturated 
patients were observed in this sample. 
 
4.6 Differences Between Male and Female TCM/CAM Users 
To explore sex differences in the use of TCM/CAM, a final subset analysis of the study population was 
conducted. Male and female TCM/CAM users were compared across relevant socio-demographic, 
medical, and cultural characteristics using bivariate methods as described previously. 
 
Twenty-eight users (70.0%) were female and the only significant difference between the two groups was 
the length of disease duration (p < 0.001). Although females used a higher proportion of TCM/CAM 
therapies, except for herbal remedies (72.7% vs. 57.1%), acupuncture (9.1% vs. 7.1%), and qi-gong 
(27.3% vs. 7.1%), no statistically significant differences were noted in the types of TCM/CAM therapies 
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used by males and females in this study population. A comparison of study variables between male and 
female TCM/CAM users is shown in Table 4.9. 
 
Table 4.9 – Comparison of TCM/CAM users by sex. 
Variable Male Female t (df) OR 95% CI P-value 
Age (years, mean ± SD) 63.6 ± 13.4 57.1 ± 16.6 1.155 (37) n/a 0.255 
Disease Duration (months, 
mean ± SD) 0.0 ± 0.0 3.2 ± 2.5 -4.84 (13) n/a <0.001 
 n (%) n (%) X2 (df)   
Prior TCM/CAM 5 (45.5) 20 (71.4) 2.315 (1) 3.000 (0.71, 12.69) 0.128 
Marital Status      
   Single* 1 (9.1) 9 (32.1)    
   Married 10 (90.9) 19 (67.9) 2.201 (1) 0.211 (0.023, 1.912) 0.228 
Education Level      
   < High school diploma 5 (45.5) 9 (32.1)    
   ≥ High school diploma 6 (54.5) 19 (67.9) 0.608 (1) 1.759 (0.422, 7.333) 0.435 
Household Income      
   ≤ $40,000 9 (81.8) 14 (50.0)    
   > $40,000 1 (9.1) 3 (10.7) 0.292 (1) 1.929 (0.17, 21.54) 1.000 
   Did not respond 1 (9.1) 11 (39.3) 3.665 (1) 7.071 (0.77, 64.58) 0.113 
Cancer Type      
   Colorectal 1 (9.1) 5 (17.9) 0.466 (1) 2.174 (0.22, 21.08) 0.655 
   Liver 1 (9.1) 0 (0.0) 2.612 (1) n/a 0.282 
   Lung 2 (18.2) 2 (7.1) 1.046 (1) 0.346 (0.042, 2.831) 0.562 
   Naso-pharyngeal 2 (18.2) 0 (0.0) 5.366 (1) n/a 0.074 
   Non-Hodgkin’s lymphoma 0 (0.0) 2 (7.1) 0.828 (1) n/a 1.000 
   Oral 1 (9.1) 0 (0.0) 2.612 (1) n/a 0.282 
   Other 1 (9.1) 4 (14.3) 0.191 (1) 1.667 (0.17, 16.83) 1.000 
   Unknown 1 (9.1) 2 (7.1) 0.042 (1) 0.769 (0.063, 9.454) 1.000 
Conventional Therapies      
   None 2 (18.2) 5 (17.9)    
   Surgery 3 (27.3) 8 (28.6) 0.007 (1) 0.938 (0.197, 4.460) 1.000 
49 
   Chemo/Radiotherapy 6 (54.5) 15 (53.6) 0.003 (1) 1.040 (0.256, 4.218) 0.956 
Survey Language      
   English 2 (18.2) 9 (32.1)    
   Chinese 9 (81.8) 19 (67.9) 0.760 (1) 0.469 (0.084, 2.634) 0.461 
Place of Birth      
   Canada 0 (0.0) 1 (3.6)    
   Outside Canada 11 (100.0) 27 (96.4) 0.403 (1) n/a 1.000 
Parental Place(s) of Birth      
   Canada 0 (0.0) 0 (0.0)    
   Outside Canada 11 (100.0) 28 (100.0) n/a n/a n/a 
Language Spoken at Home      
   Official language 1 (9.1) 1 (3.6)    
   Non-official language 10 (90.9) 27 (96.4) 0.495 (1) 2.700 (0.15, 47.39) 0.490 
Living Situation      
   With immediate family 11 (100.0) 28 (100.0)    
   With extended family 0 (0.0) 0 (0.0) n/a n/a n/a 
Note: Unless a t-test was performed, for those variables where the OR is not available there is a null 
value in the 2 x 2 table. 
* Includes widowed, separated, and divorced patients. 
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5. DISCUSSION 
The Canadian population is expected to grow in the decades to come, mainly through immigration. By 
2017, the number of Chinese individuals residing in Canada is expected to be 1.8 million; an increase of 
80% from the 2001 census.140 Importantly, immigrants to Canada must adapt to a new social system. 
Along the way, they contribute new values and practices and adopt the prevailing cultural paradigm. 
However, many ethnic groups, including Chinese, maintain some of their native identity through 
language, health beliefs, folk practices, and other customs. To date, very little is known about 
TCM/CAM use among Chinese cancer patients. 
 
Andersen and Newman’s model of health service utilization offered the theoretical framework that 
guided this research. According to this model, while the need (illness level factors) for healthcare is the 
primary factor determining use of healthcare services, predisposing and enabling factors are also critical. 
In particular, culture-specific predisposing factors have been acknowledged to impact healthcare 
utilization in the Chinese population.141, 142 As well, this theoretical framework has been used to guide 
previous research in CAM utilization.143-145 In this study, it was found that in addition to the need to use 
TCM/CAM, most likely due to side effects from chemo- and radiotherapy, predisposing cultural factors 
such as immigrant status and speaking a non-official language at home provide a superficial glimpse at 
the importance of investigating cultural influences in choosing CAM for cancer care. Such variables 
appear to be proxy measures of acculturation and warrant further investigation. Further research with this 
population (Phases Ib, II) will attempt to uncover further predisposing and enabling cultural factors, such 
as beliefs surrounding cancer and its causes/prevention and attitudes towards conventional and CAM 
therapies. In depth investigations will no doubt help to elucidate the cultural influences in the use of 
CAM in cancer care of not only Chinese-Canadians, but also other ethic minorities residing in Canada. 
For example, research has shown that Chinese patients hold strong beliefs that cancer and other life-
threatening diseases are caused by an increase in heat and an imbalance of yin/yang within the body.146-
150 Thus, therapies such as qi-gong, tai chi, and acupuncture which attempt to regain energy flow and 
restore balance may be more desirable and philosophically congruent with their cultural beliefs, as 
compared to conventional cancer treatments which are considered to be too strong and produce far too 
many severe side effects.110-113 
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5.1 Utilization of TCM/CAM 
This study found that approximately 44% of newly diagnosed Chinese patients with various cancers have 
used or were currently using TCM/CAM therapies since being diagnosed with cancer. The distribution of 
cancer types in this sample was comparable to the 2006 incidence estimates for BC.151 The prevalence of 
TCM/CAM use found in this study is comparable to studies conducted in Canada with a majority 
Caucasian population53-58, 61-64 and to studies conducted in the United States with Chinese-American 
cancer patients.102-105, 108 However, the prevalence of TCM/CAM use is somewhat lower than observed in 
studies conducted in China, Hong Kong, and Taiwan.100, 101, 106, 107 This result may be due to increased 
availability and accessibility and general acceptance of TCM/CAM in Asia as compared to North 
America. Furthermore, a minority of patients used TCM/CAM prior to their diagnosis. The increase in 
use after diagnosis is a phenomenon that has been reported elsewhere in the literature and can be 
attributed to patients’ need to try all available treatment options, ease the side effects of conventional 
therapies, and to become more active in the treatment decision-making process.82 
 
The types of TCM/CAM therapies used by patients were similar to patterns observed in most other 
studies, with the exception of herbal remedies and vitamins/minerals. The proportion of patients using 
herbal remedies was more similar to that seen in studies conducted in Asia with Chinese cancer 
patients,100, 106 whereas use of vitamins/minerals were more congruent with studies conducted in Canada 
with Caucasian cancer patients.61, 63 This observation shows that Chinese-Canadian cancer patients are a 
distinct group and cannot be homogenized with either Chinese patients overseas or with the general 
Canadian population and highlights the need for cross-cultural research and exploring the influence of 
ethnicity and culture in understanding CAM use in patients with cancer. Interestingly, despite recent 
evidence demonstrating the effect of acupuncture in reducing the signs and symptoms of chemo- and 
radiotherapy-induced nausea and vomiting,152, 153 only a few patients reported using acupuncture as 
compared to other studies.51, 64 This is most likely due to the fact that this study focused on newly 
diagnosed cancer patients, many of whom had not yet begun conventional cancer treatments. However, 
upon review of the data, it was observed that of the three patients who reported using acupuncture for 
their cancer care, two reported having had or currently undergoing chemo- and/or radiotherapy. 
 
The only socio-demographic factor associated with TCM/CAM use was female sex. Female sex has been 
widely documented as being associated with CAM use in cancer populations;61, 66, 82, 95, 98, 99, 106 however, 
the trend of lower income towards significance is inconsistent with previous research. Although several 
studies have documented no association between income and CAM use, only one other study has 
demonstrated that TCM/CAM users tended to have a low total household annual income.65 Such a 
finding seems counter-intuitive considering the fact that most CAM therapies are not covered under 
provincial and/or private healthcare insurance and thus the majority of costs associated with CAM are 
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consumer-born. This finding may be the result of several potential factors including the fact that a large 
proportion of patients chose not to respond to this survey item. As a result, conclusions drawn may not 
reflect the true population. Imputing a high income classification to those patients who did not report 
their income negated the association between low income and TCM/CAM use; however, this may be the 
result of selection bias due to small sample size. Also, it was shown that less acculturated patients were 
more likely to report a low income. This finding is consistent with previous research.154 These patients 
may have stronger ties with family or friends in their country of origin who have the means to send 
various herbal remedies or supplements overseas. An ad-hoc analysis did not show that either low 
income or less acculturated patients were more likely to use so-called “free” TCM/CAM (support groups, 
tai chi, qi-gong, and prayer) compared to acculturated patients. Furthermore, studies that found 
associations between higher income or SES and CAM use were conducted with a sample representing the 
dominant culture; in the case of North America, Caucasian. It is likely that these patients were highly 
acculturated and thus used disposable income as a means to try any and all possible cancer treatments. In 
this study, cultural factors may play a greater role in predicting TCM/CAM use. Less acculturated 
patients may have a stronger belief in the effectiveness of TCM/CAM in the treatment of cancer and thus 
chose to use such therapies despite personal financial costs. Later phases of this study will attempt to 
uncover if such beliefs are in fact predictive of TCM/CAM within this population. 
 
Medical and cultural factors were also evaluated with bivariate analysis. Medical characteristics 
associated with TCM/CAM use were prior use of TCM/CAM and having received or were currently 
receiving chemo- or radiotherapy, and have been reported in previous studies of cancer patients, mostly 
for the reduction of symptoms associated with such conventional cancer treatments.57, 61, 62, 72, 77, 88, 101, 104, 
106 The BCCA advises patients on its website to withhold from ingesting or injecting CAM modalities 
while undergoing chemo-, hormone-, or radiotherapy.155 However, it appears that Chinese patients 
attending the BCCA are either disregarding this recommendation or are not properly educated on the 
matter. This finding is a cause for concern, as many herbal remedies used in cancer care have been 
implicated in several herb-drug interactions leading to decreased effectiveness of conventional medicines 
and other more serious adverse events, including patient fatalities.156-160 Development of culturally-
sensitive education sessions for newly diagnosed patients may be warranted to help prevent adverse 
events. Furthermore, as opposed to previous studies which report CAM use as a “last resort” for cancer 
patients, this study documented that TCM/CAM is frequently used by newly diagnosed Chinese patients 
and as such discussions about CAM need to occur early in the diagnosis so that healthcare practitioners, 
along with patients can implement an effective treatment strategy. With respect to cultural characteristics, 
immigrants, that is, those patients born outside of Canada and those reporting speaking a non-official 
language most frequently at home were more likely to use TCM/CAM therapies. As well, completion of 
the Chinese version of the questionnaire showed a trend towards significance. Such findings further 
support the effect of acculturation, or lack thereof in the use of TCM/CAM for cancer care. Healthcare 
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practitioners in the oncology setting must be aware of the fact that less acculturated patients may be more 
likely to use TCM/CAM so that they can provide optimal cancer care. 
 
After controlling for all other variables with logistic regression analysis, prior TCM use, immigrant 
status, and low income remained significantly associated with TCM/CAM use. Interestingly, patients 
who chose not to respond to the question regarding income were less likely to use TCM/CAM. Although 
this finding was not significant, it lends credence to the possibility that these patients behave similarly to 
those in the high income category and that future studies in the Chinese and other ethno-cultural 
populations can use the technique of imputation to analyze data and draw valid conclusions while 
maintaining appropriate statistical power. Imputation is a technique based on the strategy of using known 
attributes to impute unknown attributes, that is, patients with complete data who are similar to patients 
with missing data with respect to other factors are randomly selected to replace the missing data.161 As 
well, the data, as discussed previously indicate that low income patients were more likely to be less 
acculturated (immigrant status and completion of Chinese questionnaire). Using the logic described by 
Boon et al.,57 this finding supports the argument that underlying cultural characteristics explain 
TCM/CAM use and that low income may be a proxy measure of less acculturated patients. This 
highlights the importance of developing appropriate methodologies that distinguish cultural effects from 
those due to socio-economic factors when studying ethic minority populations in Canada. 
 
This study found no differences between male and female TCM/CAM users, except for disease duration. 
Male users had a significantly shorter disease duration at the time of the survey compared to females and 
the reason for this observation is unknown since there were no statistically significant differences 
between gender non-specific cancer types between the two groups. It is conceivable that since females 
had a higher proportion of surgical treatment (mainly due to cancer of the breast), a longer period of 
recovery may have been required post-surgery prior to attending the cancer centre as compared to males. 
However, cultural factors may also account for this difference between the sexes. Research suggests that 
females are higher users of healthcare services in general and in cancer populations,162-164 but within 
Chinese culture women are expected to put the needs of their family before their own and as such may 
delay medical appointments, consultations, treatments, and other healthcare services for their cancer care 
in order to maintain the status quo in their family.112, 113, 148, 165-167 Furthermore, it cannot be ruled out that 
this result is simply an artifact due to small sample size.  
 
5.2 Effect of Culture on TCM/CAM Use 
Based on the criteria for acculturation in this study, patients who were less acculturated to Western 
society were not significantly more likely to use TCM/CAM as compared to those patients classified as 
acculturated; however, with a larger sample size this finding may become statistically significant. As 
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well, a significantly higher proportion of less acculturated patients was married and had a low income. 
Such a finding is reasonable considering the trend that individuals in Western society have a steadily 
increasing rate of divorce and are delaying marriage to focus on their education and careers, potentially 
leading to higher incomes.168, 169 Other differences between acculturated and less acculturated patients 
were evident as well. The higher rate of breast cancer among acculturated patients can be the result of 
higher risk factors in that population, including exposure to carcinogens and adopting a more Western 
lifestyle, for example, higher dietary fat intake. The reason for all patients with prostate cancer to be in 
the less acculturated is unknown; however, it is hypothesized that small sample size is to blame. Less 
acculturated patients had a higher proportion of having parents born outside of Canada. This was to be 
expected as one of the criteria for classifying less acculturated patients was that they were immigrants 
and as such it would be highly unlikely that such patients would have had parents born in Canada. Also, 
more patients in the less acculturated group reported speaking a non-official language at home. Future 
analyses within this population may benefit from including language spoken at home as another criteria 
in the definition of “less acculturated,” as such a factor is an important aspect of the acculturation 
process.126 
 
Early findings in cross-cultural research indicate that cultural factors influence cancer patients’ use of 
CAM. Specifically, strong associations between race/ethnicity and prevalence and types of CAM used 
have been identified.104, 105, 108, 170-172 Although this study did not replicate the previous findings 
supporting younger age, female sex, and higher SES with use of CAM for cancer care, this study did 
confirm that previous or current use of conventional cancer treatments, especially chemo- or radiotherapy 
was strongly associated with use of TCM/CAM. In those previous studies, as in the current study, a 
recurrent theme suggested that in addition to alleviating or lessening the side effects associated with 
conventional cancer therapies, TCM/CAM therapies provided a means for patients to maintain and 
preserve their cultural heritage and identity. This desire to maintain cultural autonomy may in fact be a 
coping strategy initiated by cancer patients. 
 
Cancer, as a life event, will usually induce stress, anxiety, anger, and depression, especially in newly 
diagnosed patients. With the plethora of information, new terminology, and treatment options, cancer 
patients may find one or more ways to physically and psychologically cope with their diagnosis. As 
opposed to North American patients who generally use an independent coping strategy, Chinese patients 
often cope in an interdependent manner, whereby patients exhibit a high degree of self-control and aim to 
better their situation by adjusting to it.173 Though patients cannot control their cancer diagnosis, they may 
perceive control of the situation by clinging to their traditional/cultural norms through the utilization of 
TCM/CAM. Such a control strategy can overcome a generation or two of acculturation and thus may help 
explain the effect between acculturation and TCM/CAM use within this population. 
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5.3 Study Strengths 
This study has several strengths. First, this study represents novel research in the field of CAM use and 
cancer. No previous studies have documented the use of TCM/CAM among Chinese cancer patients in 
Canada. In addition, newly diagnosed cancer patients were studied, a group often pooled with people 
who have been diagnosed for some time in previous CAM utilization studies. It is anticipated that 
researchers will build upon the methodology used in this study to further understand CAM use in other 
ethnic minority cancer populations in Canada, thus incorporating cross-cultural research in the field of 
CAM use in cancer care. 
 
Second, Andersen and Newman’s model of health service utilization, specifically the individual 
determinants of use was found to be an appropriate conceptual framework for this research. This model 
permitted the implementation of an effective strategy for the selection of variables, development of the 
measurement instrument, analysis of results, and identification of factors associated with TCM/CAM use 
within this population of study. 
 
Third, using a bilingual recruitment strategy provided a suitable methodology to maximize patient 
recruitment. Having a bilingual Chinese research assistant on site put potential participants at ease and 
secured their trust in participating in the study. Moreover, as discussed previously, all study-related 
documents were back-translated and thus were of higher quality, providing patients a sense of familiarity 
during their first visit to the cancer centre. 
 
Fourth, based on the methodology and research protocol employed, this research allows for follow-up of 
patients in future phases of the study. Changing from a cross-sectional to a longitudinal study design 
permits the study of patients as they undergo a transition from recently diagnosed to further stages of the 
illness trajectory and will enable the identification of any changes in TCM/CAM use over time in patients 
who consent to follow-up. Quantification of the themes identified in Chiu et al., qualitative pilot work 
may then be possible and build on the qualitative results of that study. 
 
5.4 Study Limitations 
This study has several limitations. First, this study has inadequate power (< 80%) to detect statistically 
significant differences between users and non-users of TCM/CAM due to the small sample size. The 
effect of the small sample size is reflective in the rather large confidence intervals observed in both the 
bivariate and multivariate analyses. Such wide-ranging confidence intervals prevent the estimation of a 
precise measure of association. However, it must be emphasized that this study reflects pilot work and 
data collection is currently on-going. It is estimated that at the end of data collection (approximately one 
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year), the number of patients will total approximately 470, providing acceptable statistical power. 
Second, the sample in this study is one of convenience, with geographical limitations to the greater 
Vancouver area in BC. These results may have limited external validity to the Chinese-Canadian 
population across the province and the nation. However, the results provide a glimpse of the use of 
TCM/CAM by newly diagnosed Chinese cancer patients. Further studies in other urban centres across 
Canada are required to confirm the results obtained in this preliminary work. 
 
Third, with less than a 50% response rate, this study suffers from response bias, potentially leading to 
results that are not reflective of the true population. No data was collected on non-respondents and thus a 
measure of how the study sample reflects the entire population cannot be established. The low response 
rate may be due to the fact that patients must complete standard BCCA admission forms during their first 
visit to the clinic and as such may not have adequate time to complete the study questionnaire prior to 
their scheduled appointment time. Also, cancer is a personal and sensitive topic and many patients may 
feel uneasy disclosing information about their disease. This is especially true within Chinese culture, 
who’s members hold strong beliefs that a diagnosis of cancer is considered a “death sentence” and 
discussing the disease with persons outside the immediate family is viewed as taboo.174, 175 
 
With respect to limitations in the measurement instrument, the impersonal format of data collection (self-
administered survey) may have prompted unease and distrust among patients potentially leading to non-
disclosure of TCM/CAM use. This issue was attended to by providing the questionnaire in the patients’ 
preferred language (Chinese and/or English) and by having a trained bilingual research assistant on-site 
to provide any support to patients. Also, as indicated previously, terminology is of uttermost importance 
when conducting cross-cultural research and as such, the measurement instrument was back-translated to 
ensure proper use of language in this context. However, patients may still not have associated TCM with 
CAM and thus did not report its use. 
 
Furthermore, this study is hindered by the fact that no relevant clinical outcomes were measured; 
however, it should be noted that assessing the prevalence and identifying factors associated with 
TCM/CAM was the central focus of this research. Future research should investigate the level of 
satisfaction with TCM/CAM among Chinese cancer patients as well as overall effectiveness of various 
TCM/CAM modalities in reducing tumour size and side effects from conventional treatments, as well as 
the effect on patients’ quality of life using the paradigm of good evidence-based medicine. The next 
phases of this study will assess and compare quality of life between users and non-users using the 
European Organisation for Research and Treatment of Cancer Quality of Life (EORTC-QOL) scale. The 
EORTC-QOL is a widely used quality of life measure and provides reliable and valid results in Chinese 
cancer patients.176 
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Also, due to the limited amount of time patients would have to complete the questionnaire, only a limited 
number of cultural variables were included. Future phases of this study will compensate for this 
limitation by probing deeper into the cultural influences affecting TCM/CAM use through the use of a 
longer, in-person interview at the patient’s preferred location. As well, defining and measuring culture, or 
as in this study’s case, acculturation is a difficult task. Several other studies assessing use of health 
services by Asian populations have utilized single-item proxy measures, either alone or in 
combination.120-125 It is believed that the proxy measures used in this study were adequate in classifying 
patients as either acculturated or less acculturated, since combination measures better mimic multi-
dimensional scales. Adding the variable “language most frequently spoken at home” to the definition of 
being acculturated in this study did not alter the reported findings. However, it is important to bear in 
mind that single-item proxy measures provide only a shallow measure of acculturation and results may 
become high variable when different measures are used.119, 126 For example, in this study, immigrant 
status was independently associated with TCM/CAM use, but when combined with survey language to 
define patients according to their degree of acculturation, the association was no longer significant, thus 
leading to variable interpretations of the findings. Future research in this population should incorporate as 
many single-item measures as possible in defining acculturation, or if feasible, use a reliable and valid 
multi-dimensional scale such as the SL-ASIA.    
 
5.5 Challenges Linking Previous and Future Research 
The pilot work by Chiu et al., assessed the use of TCM/CAM in Chinese cancer patients and challenged 
researchers to continue work with this population in the form of larger, national quantitative research 
endeavors. This study is the first step towards that end. Socio-demographic and cultural characteristics 
were similar between the sample in this study and the sample from the pilot research; however, some 
differences in methodology and findings were apparent which need to be addressed in future cross-
cultural research. 
 
First, Chiu et al., recruited patients not only from the clinic, but also from a community setting and 
utilized a naturalistic, semi-structured ethnographic interviewing methodology, allowing researchers to 
obtain more in-depth information from patients surrounding the use of TCM/CAM since being diagnosed 
with cancer. The limited amount of data collected during this study will be supplemented with more 
detailed information collected during Phases Ib and II. Second, the primary reason for using TCM/CAM 
according to the focus group was due to the failure of conventional cancer treatments. However, this 
reason cannot be extrapolated to reflect the current study population due to the fact that this study 
recruited only newly diagnosed patients who had not yet begun or were not yet completed conventional 
treatments and thus would not be able to comment on its effectiveness in treating their cancer. Results 
from Phases Ib and II, whereby patients are no longer considered new diagnoses and may have 
58 
completed their conventional treatment regimen will be permissible. Third, there was a large difference in 
the prevalence of TCM/CAM use between the two groups (100% vs. 44%). This finding can be attributed 
to the fact that newly diagnosed cancer patients are often discouraged by conventional healthcare 
practitioners to use CAM while preparing for or currently undergoing chemo- or radiotherapy and 
excluded the sample of newly diagnosed patients who often return to their country of origin to receive 
cancer treatment. The patients in the pilot study were established cancer patients who had completed 
treatment and thus may have resumed their use of TCM/CAM. Thus, it is plausible that prevalence of 
TCM/CAM use will increase in the later phases of the study. Interestingly, Chiu et al., observed that 
patients found it difficult to locate credible and trustworthy TCM practitioners who could provide 
adequate cancer care and thus may help to explain the low prevalence of TCM/CAM use within this 
sample and the high proportion of users who self-medicate with herbal remedies (60%), possibly on the 
advice of family and friends. 
 
Of special note, this pilot work elucidated that TCM/CAM was an integral part of the daily lives of 
Chinese cancer patients and therefore most patients did not associate TCM with CAM. This finding has 
been reported in previous research with South Asian women residing in Canada.171 This may also explain 
the low prevalence of TCM/CAM use within this sample, despite clearly stating on the questionnaire that 
researchers were interested in both “TCM and other CAM.” This highlights the critical importance of 
terminology used in cross-cultural research. As well, it is possible that researchers must utilize other 
methods than self-administered questionnaires for data collection in ethic minority populations in order to 
deal with such nuances. Use of structured interviews, whereby researchers support patients during 
completion of the survey and clarify potentially ambiguous sections is warranted in order to collect 
reliable and valid data. Such a procedure will be implemented in the later phases of this study. 
 
Phase II of this research will involve continued data collection in order to improve the statistical power of 
the study and will transform this cross-sectional utilization study into a longitudinal outcome study 
assessing the quality of life in newly diagnosed Chinese cancer patients, comparing TCM/CAM users and 
non-users during a year follow-up. In addition, collecting more detailed information during the in-person 
and telephone interviews will be beneficial in understanding the cultural factors influencing the use of 
TCM/CAM for patients’ cancer care. Through this and other cross-cultural research, healthcare 
practitioners who encounter the heterogeneity of the Chinese cancer population will be better able to 
identify those patients who may be more inclined to use CAM therapies for their cancer care. As well, the 
endpoints for future cross-cultural research within this population should permit a clearer understanding 
of patients’ reasons and motivations for choosing to use TCM/CAM for their cancer care, leading to 
more culturally appropriate patient education, clinic assessment, and an overall improvement in culturally 
sensitive cancer care in Canada.  
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6. CONCLUSION 
Using a consecutive sample at two major cancer centres in Canada, this study examined the use of 
TCM/CAM among newly diagnosed Chinese cancer patients and found that approximately 44% of 
patients who responded to the survey were using such therapies and that sex, income, receiving chemo- 
or radiotherapy, prior TCM/CAM use, immigrant status, and speaking a non-official language at home all 
significantly influenced whether a patient used TCM/CAM for their cancer care. 
 
In guiding this research, Andersen and Newman’s model of health service utilization provided a suitable 
framework for this study. According to this model, findings revealed that in addition to need for 
healthcare services as assessed by patients’ medical characteristics and socio-demographic predisposing 
and enabling factors, cultural determinants, especially patients’ degree of acculturation strongly 
influenced a Chinese patient’s choice to use TCM/CAM for their cancer care.  
 
The large interest and availability of TCM/CAM requires that healthcare practitioners be sensitive toward 
and educated in these types of therapies and their potential benefits and dangers. This study re-
emphasizes the need for healthcare practitioners to initiate communication with their patients, no matter 
their ethno-cultural affiliation, and to inquire about and develop an interest in their patients’ health beliefs 
and practices, especially within an oncology setting. A national study utilizing a random sampling 
procedure is required to evaluate the influence of ethnicity and culture on the use of CAM in patients 
with cancer. With an increase in the number of immigrants and the increasing diversity of the population, 
the effects of culture on the health practices of the Canadian population are important considerations in 
developing a more responsive health policy. 
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